The growth and economic development of the drug industry in the United States by Dumas, Leo Paul
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Dissertations and Theses (pre-1964)
1938
The growth and economic
development of the drug industry
in the United States
https://hdl.handle.net/2144/13803
Boston University

LIBRARY
BOS TON
UNIVERS I TY
im B U SyiS ESS IjJ,
ADMINIS TRATION
Class No. ^ 6 ^
Book No.
Acc. No. lltiOf
Date (e '/C- 3f
BOSTON UNIVERSITY
College of Business Administration
THESIS
The Growth and Economic Development
of the Drug Industry in the United States
by
LEO PAUL imrAS
(Holy Cross College- A. B. -1936)
Submitted in partial fulfillment of
the requirements for the degree of
iv'iASTER OF BUSINESS ADMINISTRATION
1938
Digitized by the Internet Archive
in 2015
https://archive.org/details/growtheconomicdeOOduma
PREFACE

PREFACE
5 The youth of the United States compared to the age of
other great nations has given her the advantage over them
that she could profit by their experience. But in another
way it worked to her disadvantage: she has from tine to
time entered into fields of enterprise wholly new to her
in competition v/ith old nations accustomed to them from the
first, and participants in each stage of their development.
But it has never entered one with less knowledge of prin-
ciples and methods than that of v/hich she is now the queen,
the drug industry.
The drug industry constitutes at the present time one of
the most important industries in the United States, and in
volume of output, this country ranks first among the nations
of the world. The task here taken is to set forth the steps
whereby the drug trade has become so highly organized as v/ell
as so iiaportant, I v;ill attempt to treat of the development
of the industry keeping in mind certain economic laws and
principles, particularly the law of "demand and supply''. An
attempt will be m.ade to show how the dem.and for "cure" necess-
itated a supply of some form of drugs, and an oversupply of
these drugs led to a demand for new uses and nev/ outlets on
the part of producers- resulting, as time marched on, in a
more and more complicated and specialized trade.

This method of presentation is a developraent of one and
one-half years of business study at the graduate school of
Boston University, coupled v/ith extensive readings in all
phases of the drug industry, Ehe major part of the data given
on the early history of the drug industry was acquired from
undergraduate class notes taken while studying chemistry and
biology. Statistics concerning the growth of the trade were
taken mostly from various bulletins and docuiients issued by
the united States Bureau of Foreign and Domestic Commerce.
I sincerely believe that no book has before been written
on this subject. All information gathered in this thesis was
collected from various contacts with drug firms, studies and
readings on different phases of the subject. The data so
assembled is presented in a systematic and chronological order.
The work has necessarily been restricted at several points.
The early history of the industry has not been given more
space because progress in that period was relatively slow. In
other parts, certain phases of the trade v/as dilated upon but
briefly since an adequate discussion of all phases in the in-
dustry would be prohibitive. However, I have atteinpted to bring
out the most pertinent and important points.
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THE GROV/TH MfD ECONOiCEC DEVELOPMENT
THE DRUG Il^DUSTRY IN THE IMITSD STATES

INTRODUCTION
The drug industry in the United States knows of no ancient
history as the trades of Egypt, Persia, Arabia and England.
It knov/s of no time when the apothecary v/as imbued with some
of the traditions of the Alchemists, using certain harmless
devices to impress the populace with the idea that there was
something uncanny and faintly allied to magic in the pov/er of
its simple preparations. Even as late as 1600, England's phar-
macist was elevated to the pedestal of an idol in the eyes of
the public. One could picture that great man with crowds of
city ladies and men gathering in the dark, mysterious, bottled-
paned shops, with their swinging crocodiles and rows of fat
drug jars containing the syrups and simples, the conserves and
ointments which formed the staples of the time. Their stock
consisted primarily of crude drugs, herbs and roots, gum candles
spices and other articles even more foreign to the trade.
Unlike this situation, v/e can safely say that the history
of the iimerican drug industry dates back to but the relatively
recent days of the Puritans, Naturally, there was illness aiaong
them with the result that the necessity of relief becaiiie the
mother of the invention of cure. Here and there, a man or
womjan v/ould boil dov/n a certain herb, and \)j "trial and error",
hit or miss, would sooner or later find one that v/ould relieve
the sick patient. Through a process of elimination, certain drug
became standard reliefs for certain ailments as well as basic

elements for the compounded medicines that are available today.
It becomes evident, then, that if the ijiierican drug industry
is great today, it is largely due to the ever-present "necess-
ity", that necessity of relief, which was the seed destined
to blossom into a major trade.

EARLY DEVELOFTrlE]^ OF THE DRUG INDUSTRY I6Q0 -I799
Although it is true that up to this tine the art of curing
was based on erapirical experience and superstitious tradition,
the seventeenth end eighteenth centuries enjoyed definite
progress. Men of science, both here and abroad, began to real-
ize that the conquest of disease depended on tv/o things, narae-
ly,'that first, the nature of the disease had to be studied
until the cause was found, and secondly, that cheraistry had
to be regarded as a pure science undiiniaed by the trailing
clouds of AlcheiL-y, However firLi v/ere these resolutions, it
was undisputed among the men of science that organic substances
could be transforraed only by power of the Vital Force, Had they
gotten away from that idea, I believe that the medical and
chemical sciences would have progressed more rapidly at this
stage. Nevertheless, these facts concerning organics were bel-
ieved to be a metaphysical certainties v/ith the result that no
one even attempted to conquer the organic world through science
until as late as 1828, when V/ohler discovered that urea could
be artificially made from isocyanate of aiTjrionium. This incid-
ent automatically revolutionized the field of chemistry and
opened the way for further experiments along that line. Its
effect upon the industry as a ivhole will be shown in later
chapters.
Although it is true that in the early stages of tne drug
industry the staples of the trade, the legitimate drugs and
medicines, were gathered from all quarters of the globe (with
the principle source of imports being Iv.exico- followed by
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uentral and South America), domestic cultivation of crude
botanical drugs v;as constantly being encouraged, i-vmerican
colonists were requested to search for such articles as guiiis,
dyes and other products, v/ith stipends given by the Governors
of the tine for any new discoveries. Although, in spite of
these encouragements, the progress made in the drug industry
was relatively slov; during the course of the seventeenth cen-
tury, I believe that at this time a foundation was laid dov/n
to support the prospective tower of the trade, I'or instance,
it v/as as early as 1620 that the first historical mention of
drug manufacturing was made. A document was sent to i^'rancis
Wyatt, then governor of Virginia, requesting him to invite
attention to the industrial possibilities that might be found
in the making of "Oil of iValnut s" , and authorizing him to use
such apothecaries as might be necessary to assure its proper
production. In the fulfillment of such a request, a small
shop v/as opened for this purpose with the intention that the
enterprise was to be conducted on a non-profit basis. Unfort-
unately, the product did not become as popular as was antic-
ipated and because of the lack of adequate means of distrib-
ution through the State of Virginia, the factory was closed
dovm.
As a direct result of this unfortunate incident, the first
half of the eighteenth century did not contribute much to the
development of the drug trade, except that, it may be pointed
out, cultivation of crude botanicals was still being encouraged.
*1
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No business nan, however, during these fifty-odd years
,
nurtured the thought of manufacturing these rav; materials,
due partly to the fact that the first factory in Virginia had
failed, and partly to the fact that they understood onlj^ too
well the psychological attitude of the consulting public which
consisted of the belief that 'simples" was the safest means
of cure. It was still the creed of the populace and pharmacists,
for instance, that ''tar water" v/ould relieve and even cure
such ailr.ents as scurvey, bad blood, small pox, pleurises,
comsuniption, coughs, ulcers, lovmess of spirit, loss of appetite
and other distempers. It v/ould seem as though the people just
could not pull away from the idea that they were all predest-
ined and that the Vital Force v/as the only cure, using natural
herbs as His ivxediur.i of curing.
Fortunately, such superstitious elera.ents v/ere less evident
during the last half of the eighteenth century, probably due
to the growing popularity of the Pharmacopoeia. It was not
until 1778 that the first American issue of this periodical
v/as published. A second edition was issued hj the Massachusetts
Medical Society in 1808, but, unfortunately, neither fostered
attention or circulation v/ith the result that for some years
thereafter drugs still continued to be dispensed in accord-
ance v/ith the Pharraacopoeiae of foreign countries. These dom-
estic editions, though not too successful, did educate many
American druggists, particularly wholesale druggists, that the
information contained in such a periodical v/as indispensable.
Ii
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Unfortunately, there is no data from which we may estimate
the number of druggists doing business in the United States
at the end of the eighteenth century. The New York Directory
for 1786 mentions the names of only five retailers and two
wholesalers. The outstanding wholesale house at this time v/as
that of Jacob Schieffin, founded in 1794. Incidently, this
house v/hich was founded nearly a century and a half ago is
still doing business in Nevir York, under the control of his
descendants.
As we look back upon the early history of the i-imerican
drug trade, we find that the progress made during the seven-
teenth and eighteenth centuries was very slow. This v/as prob-
ably due largely to the fact that adequate means of trans-
portation and communication were not available thus limiting
the extent to v/hich "division of labor" could be gainfully
exercised. The druggist had to manufacture his pills, package
them himself and then try to sell them in his store. Because
all of these operations had to be performed by one man, he
had no time to specialize along any one line. Consequently,
should a druggist become fortunate enough to secure a good
formula or prescription, he would be rather reluctant to reveal
it to his competitor, lest he should lose his trade in the
sale of that medicine. In other words, there was a distinct
lack of cooperation betv;een those druggists located in neigh-
boring areas where means of coirmiunication were available.
Such a condition was short-lived after the first success-
I
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ful publication of the United States Pharmacopoeia and the
opening of the Kxle Canal. The latter factor provided the
element of speed and efficiency in transportation, while the
former fostered cooperation and confidence betv/een pharmacists.
Consequently, we can safely say that these two developments
were unquestionably the major factors that fostered a rapid
progress in the fields of manufacturing and marketing during
the nineteenth century.
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DEVELOPIIENT OF TIffi DRUG INDUSTRY I800-I899
Pharmaceutical Associations and Periodicals
As has previously been mentioned, the first two publications
of the Pharmacopoeia had not been successful. However, in 1820,
the first edition of the United States Pharmacopoeia appeared,
and this work, v/hich has passed through successive decennial
revisions up to this time, has and is still regarded the world
over as the standard in all manipulation of drugs and medical
chemistry. The originators of this issue recognized the vital
v;eaknesses adherent to the two previous publications and under-
took to readjust its form. From the very first, this issue
attracted public attention and immediately, instead of we impor-
ting foreign pharmacopoeiae , were exporting our own. It has
since become the outstanding authority on all processes involved
in the handling of drugs, from the identification of crude
materials to the final stages in its preparation for the use
of invalids. The names of Proctor, Maisch and Rice are insep-
arably connected with the early issues of this great work.
During this era, pharmacists became, more and more, extraverts
with regard to the limited knowledge of drugs that they poss-
essed. They realized that, toserve the public best, they must
exchange formulas, prescriptions and general knov/ledge of the
field. This policy resulted in the formation of the "American
Pharmaceutical Assosciation" in 1852, the first association of
its kind in America, The organization was composed of tv/enty-
ia;
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one active pharmacists^ It was ageed that no member v;as to keep
from any other member information which he had acquired in the
line of new formulas, discoveries and the like since the last
meeting. Such meetings were held primarily to discuss matters
relating to the welfare of the industry. One of the effective
features of its work v;as the annual publication of its work
and proceedings, an edition which presented a complete review
of the scientific progress of pharmacy. It also rendered a
monthly publication of the " American Pharmaceutical Association
Journal V
This organization became so successful that 18 years later,
1870, pharmacists of various states cooperated in forming
State Associations, the first of v/hich was organized in 1870,
The wholesalers of the west followed suit by organizing under
the name of " The V/estern vJholesale Druggists' Association
This ¥/as founded in 1876, Five years later, 1882, many of the
prominent eastern druggists joined forces with the western
wholesalers, at a meeting held in Cleveland, Ohio, and at this
time, the name of the organization was changed to " The Nat-
ional Wholesale Druggists' Association
Still another great development during the nineteenth cen-
tury along the line of publications was the pharmaceutical press,
jlmong the most prominent periodicals that came into being
,
during that period, were such v/eekly papers as. The Oil, Paint
* In I9I5, its membership numbered 2,490
1
I
i
I
mi
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and Drug Reporter, The Pharmaceutical Era and the Shipping
List, all of rjew York; semi-monthlies like the iVtnerican
Druggist and rharmaceutical Record, of New York, and such
monthly journals as. The New Druggist, of Boston; The National
Druggist, of Saint Louis; The Druggists' Circular and Chemical
Gazette, of Nev; York; The American Journal of Pharmacy, of
Philadelphia; The Pharmacment-ische Rundschan, of New York.
Besides these, there came into existence many College and
Society publications, together with periodicals of local inf-
luence and a considerable « of papers issued by prominent drug
firms and manufacturing houses.
Effect: The advent of these associations and their pub-
lications displaced all superstitious beliefs which heretofore
v/ere inherent in the people as well as the druggists. The
pharmacist no longer considered himself an idol in the eyes
of the people, nor did the populace think of him as a "mystic".
The druggist became av/are of the fact that he was now in a
competitive industry which v/as becoming more and more stand-
ardized. New drugs as well as nev; methods of preparation were
constantly being introduced and made public in the ir^harmacopoeia.
He began to realize, also, that if he were to remain in
business, he had to a.dopt these nev/ policies else his competitor
take his business away from him, for the Pharmacopoeia pub-
lished all medicines approved by their committee, together
with their uses in the relief of certain ailments. As a result,
people learned these and soon began asking the druggist for the
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med icine s by their nar.es.
Just as the American investor of today has faith in the
stocks of those companies listed on the New York Stock Ex-
change, so did the people of the nineteenth century have
confidence in the preparations listed in the Pharmacopoeia.
Before anything was listed in the issue, it had to he fully
tested and approved hy their coimiiittee, For instance, it v/as
not until 1840 that the process of "percolation" occupied a
place in this publication although it had been discovered ten
years before. It was not until 1850 that the publication gave
any formulas for the preparation of fluid extracts. In this
year, seven of these formulas v/ere given, and by 1890, the
number had increased to 88, -today such extracts are innuiaerable
,
Again, as a result of these publications, druggists, chem-
ists and scientists cared no longer to have but a receptive
attitude toward the then limited knowledge of drugs, but on the
contrary, he himself began to experiment along those lines.
Rather, he now had an incentive. He could probably become
famous by discovering some new drug or preparation, because now
his name v/ould be included in the Pharmacopoeia, should he be
fortunate enough to succeed. Needless to say, this led to
inniunerable discoveries along the line of new products, nev/
methods, and new cures for prevalent ailments.
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Nev/ Discoveries
:
Of all the discoveries made during this period, probably
the most outstanding v/as the discovery of organic chemistry by
Wohler, in 1828, when he found that urea could be manufactured
artificially from isocyanate of amiiioniunT This v/as really the
first step toward the synthetic production of organic compounds.
Undue stress should not be laid dovm upon the wonderful
advances in medical chemistry at about this same tirae, ho¥\^ever.
It was at the beginning of this nineteenth century that surgical
anaesthetics came into being, partly as a result of the dis-
covery of such elements as hydrogen, oxgen and nitrogen, all
components of the air v/hich we breathe daily, and partly from
observations made by a florist. The latter 's trade v/as such
that it was necessary for him to have the flowers shipped from
the south in freight cars. He noticed, hov/ever, that under
certain conditions the flowers arrived withered and apparently
dormant. He reported this fact to able scientists, v;ho found,
upon analysis of the air contained in those cars, that blossom-
ing flowers ejected an excess of nitrogen, which compounded
with ordinary air, produced a sleep-inducing substance which
they named ''ether". After this gas had been further perfected, Dr.
Warren, of Boston, used sulfuric ether as an anaesthetic for
the first time, in 1805, on a patient suffering from phthisis
and, in 1806, used it on one suffering from asthma. Then various
* Previously discussed, c,f , page 2.
I
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other successful experiments v/ere raade by Ives, of New liaven;
Long, of Georgia; ./ells, of Hartford and ..lOrton, of Boston, the
latter being really the first who placed ether as an anaesthetic.,
on October 16, 1846, in the xV.assachusetts General Hospital,
There is, perhaps, no particular in v/hich the development
of the drug industry ov/es its rapid rise than to the improve-
r
irients in production that occurred during this century. L.p to
this time, the apothecary was obliged to cut and roll his pills
by hand and to make his plasters with the aid of a "spreading
iron". He powdered his drug in a stone or iron mortar and made
his tinctures in a wide mouthed jar with the aid of a stirring
stick. Now, small hand-machines were being invented and intrd)-
duced, an apparatus by v/hich he could increase his production
ten-fold* within the same length of time. His pills became
uniform in size and shape, his plasters becarae standardized as
to quality and thickness,
Ivieanwhile, scientists discovered that pharmaceutical fluid
extracts could be made through a process of "percolation",
coiffiTLonly called displacement, This is a process by which the
powdered drug, iJlaced in a suitable vessel, is deprived of its
soluble constituents by the descent of a solvent through it,
thereby causing the solvent to absorb the wanted ingredients
from the pov/der. In view of the fact that this process was
essentially an .Ajaerican invention and that it had never been
Modern machines can now produce 5,000 pills per minute.
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been heard of before, caused pharmacists to be rather reluctant
in accepting it, and in fact, it did not become popular until
ten years later, v/hen the Pharmacopoeia gave the process its
official recognition in 1840, However, this publication gave
no formula for the preparation of fluid extracts until 1850.
Another innovation v/as the so-called "elixus" which was
originated at some time in the later thirties. For a time, this
term was used almost exclusively by manufacturers to designate
their aromatic, sweetened, spiritous preparations v/hich contained
comparatively small quantities of active medicinal substances,
but no formula under the name was published for the use of the
people and druggists until 1859.
The first sugar-coated pills made in this country were man-
ufactured by Bullock & Renshav/, of Philadelphia, and the Tilden
Company, of New Lebanon, N.Y. . The use of gelatin capsules as
a means of administering nauseous remedies in a readily assim-
ilable condition was also the direct result of American enter-
prise in the late fifties. This new process had originally been
outlined by i.othes, of Paris, but the success attained in pop-
ularizing it was due to the efforts of H. Planters & Sons.
It is difficult for us to realize that it was not until
after I8S5, when the i^merican surgeon, Beaumont, made his care-
fully conducted observations upon the phenomena of digestion
in the stomach, that the function of the gastric juices were
revealed, his investigations, which lasted until I8b3, stimul-
ated and suggested the course for subsequent researches, and, in
mi
1836, when the active principle of the gastric juices was
discovered by ochuuan, he gave it the name of "pepsin". From
the drug industry's point of view, the history of pepsin began
v/ith the introduction of Scheffer's pepsin, in 1872. This
preparation was made hj a simple and practical method, developed
at about that time, known as the salt process. This new process
proved itself to be a great improvement over all the proceed-
ing m.ethods of obtaining the ferments from the stomach. A fev/
years later, about 1879, the original form of pepsin in scales,
"free from added substances or reagents"*, was introduced by
Fairchild, and the advent of this preparation of phenomenal
strength had the effect of causing great activity in the manuf-
acture and im,provemient of the coxiimercial pepsin.
Another great development along individual lines, v/hich
carried much weight in aiding the progress of the industry, v/as
the practical recognition and application of pancreas ferments,
due to the efforts of Fairchild . In 1880, he introduced the
"extractum pancreatis", which contained diatase for the conv-
ersion of starch, trypsin and albumen, and to emulsify fennents
for the digestion of fats. Again, in 1884, he proposed methods
by which cov/'s m.ilk could be modified and adjusted to a closer
resemblance of huiaan milk by the conversion of caseine, through
the use of trypoin, to the soluble and peptone -like bodies for
which the latter milk is peculiar.
Premiedical class notes 1934/5/6.
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The first improvement upon the antiquated method of applying
plasters to the human body was the invention of an India-
rubber porous plaster by Dr. Schecut, a naval surgeon. He sold
his rights in the plaster to Thomas Allcock, but the latter,
failing to make its manufacture profitable, sold it to Dr.
Braudreth. At that time, the only commercial plasters v/ere made
of isinglass and resinous mixtures, some of which were spread
on cloth and plaster skins. It was in the year 1867 that Sesbury
and Porter began the experiments which finally resulted in the
use of rubber in medicinals and surgical plasters.
A new, distinctively American form of medication came into
existence under the name of "tablet trituratus", introduced by
Dr. R. M. Fuller, in 1878, These were made by a method in which
the active ingredients were triturated, or ground, with either
plain sugar of milk, or v/ith a mixture of sugar of milk and
cane sugar, into a paste which was pressed into tablets in
suitable molds. By this process it V7as possible to administer
small quantities of such potent medicines as alkaloids, concen-
tration, etc,, in a convenient, palatable, and readily sol-
uble form.
Effect: Prior to the nineteenth century, druggists, as well
as the people, believed that the certain simples knovm at the
time had the inherent possibility to cure practically any ail-
ments- the best example of v/hich was that of "tar water", as
previously mentioned-. However, these new discoveries cast those
beliefs aside. Scientists realized the fact that if an
1
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illness was to "be relieved, the cause of the illness had to be
found and attacked. This is what happened v/hen they began
diagnosing storaach ailments- its accompanying result v/as
that people began having greater and greater confidence in the
effects and potentialities of drugs.
The discovery of organic chemistry opened the v;ay for ex-
periments along that line, and commercially, the effect has
been that, since that tiiiie, innumerable compounds of an org-
anic nature have been prepared synthetically, many of which
are of great industrial importance today being manufactured in
extensive quant ites, ivnong such compounds, there is one in
particular. Alizarine, the chief coloring principle of "madder
root", of which fully twenty million dollars worth is produced
annually from coal-tar. Oxalic acid from saw-dust and caustic
soda can be produced one-tenth as cheaply as it was when form-
ally produced from the Juice of sorrel. Not only has the chem-
ist succeeded in producing many of the most important drugs
and organic compounds in his laboratory however, but, during
the past quarter of a century, he has discovered a vast num-
ber of nev/ and interesting synthetic chenicals and pharmaceuti-
cals which has never been found in living plants and animals-
anong them are antipyrine, monoacetosalicytic acid*, exalgine,
phenacetin and others, all of which either directly or in comp-
ound enter into the manufacture of drugs, Moreover, as the num-
* Conimonly called "aspirin".
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ber of these compounds, which are of great importance thera-
peutically, is constantly increasing and such progress which
is represented by the discoveries in allied sciences has ex-
erted a powerful influence in elevating the drug industry td)
its present high position,
V\fith the introduction of machinery for the manufacturing
of remedies came standardization. Such standardizing, coupled
with government regulations relative to the manufacture of
drugs, had a most persuasive effect upon the mind of the con-
sumer. The people now believed and reacted psyc^logically to
the effect that remedies were effective, clean, healthful and
safe. This resulted in more sales per capita, V7hich,in turn,
increased production thereby influencing the manufacturer to
increase his efficiency.
The fact that pills and remedies, v/hich were previously
unpalatable, v/ere now being sugar-coated, capsuled and comp-
ounded appealed to the people through their sense of taste.
For instance, immediately after "tablet trituratis" was intro-
duced by Dr. R.M. Fuller, in 1878, unique as was the idea, this
form of administering medicine became so popular that the
manufacturers began to produce them on an enormous scale, one
manufacturer having no less than 500 different varieties of
these tablets on his price list. The fact that the people
responded to these new preparations gave the producer a more
diversified lin€ of items to fianufacture and sell, resulting in
the constant opening of new factories to take care of the demand
that was being created at this time.
(I
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Manufacturing :
Although the first raention of drug manufacturing in the
United States v/as made in I62I, due to its failure, no one
attempted to enter in this field again until 1820, At this
time, through the investigations of the French scientists, the
separate alkaloids in cinchona bark were determined and Pel-
letier soon ventured to begin their manufacture. It v/as about
the same time that John Farr started the first quinine factory
in Philadelphia. The popularity of this drug was so immediate
that John Currie soon follov;ed by building a similar plant in
New York, These two enterprises were helped by United States
Government when the latter immediately placed an import on any
f oreign-ra.ade quinine and, consequently^, the manufacturers
enjoyed a monopoly on its production. In 1879, however, quinine
was placed on the "free list" and, as a result, countries
v/hich manufactured this drug cheaper than could this infant
industry sent their surplus i^roduction here, until at the pres-
ent time, they have such a strong foothold that they nov; control
nearly one -half of the /imerican quinine market.
After the opening of the r^Jrie Canal, in I82;3, these tv/o man-
ufacturers found their enterprise to be a very successful
venture. Prior to this date, they found their market limited
to their immediate vicinity due to the unreliable, primitive
means of communication prevalent at the time, Kov/ever, after
the canal was o^^eneu, their business became very seasonal.
Instead of dragging along through the year, the manufacturer
I
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nov; had tv/o busy seasons. There v/as a great demand for his
merchandise in the spring and another rush of business just
prior to the close of navigation in the fall. Their market
expanded to all cities in llothern New York State bordering the
canal.
Other business men realized that a great demand for drugs
and phamaceuticals v/as developing and proceeded to open shop.
From that point on, manufacturing developed very rapidly. i\jiiong
the manufacturers of iiiedicinal chemicals that started in bus-
iness shortly after 1825, the following firms are worthy of
mention; Larkin & Scheffer, of Saint Louis; Herf & Freichs, of
Saint Louis; The New York Quinine and Chemical Work; Charles
Cooper & Company and Charles Pfizes & Company, of New York;
Rosengarden and Sons, of Philadelphia,
In 1850 Haskell & Merrick put upon the market a select line
of drugs, including morphine, chloroform, ether and galenical
salts. It v/ould be interesting to note in passing that, at
this time, Philadelphia was the center of trade for English
chemicals and pharmaceuticals, Boston for East India drugs,
and Hew York for Spanish, French, German and Italian drugs and
preparations. In the decade following, manj fluid extracts as
v/ell as glycerine extracts were added to the list of readj^-m-ade
supplies. One of the pioneers of the manufacturing of such
pharmaceutical supplies was Dr. E. R. Squibb, a former assistant
surgeon in the United States Navy, who organized and managed
the United States Naval Laboratory from 1854 to 1858.
I
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At the outbreak of the Civil War, I86I, many manufacturers
either v/ent out of business or consolidated v/ith other producers
due to the break in relationships between the North and the
South. I any manufacturers in the north depended on the south
for the greater percentage of their business and consequent on
the hostilities betv/een these tv/o groups, their outstanding acc-
ounts v/ere cancelled, Hov/ever, as the conflict progressed, an
enormous war demand for pharmaceuticals was created, resulting
in an increased ni.ioiber of nev/ factories. It was at this time
that Dr. Squibb acquired his incentive for the establishment of
his remarkable laboratory. Aiaong other pioneers are: The Tilden
Companj?", of Hew Lebanon; Billings, Clapp & Company and the E.L.
Patak Company, of Boston; Sharp & Dolune, and the Burrough
Bros, I.anufacturing Company, of Baltimore; Henry Thayers & Co.,
of Cambridgeport
,
Massachusetts; Vjilliam Warner & Company,
John V'/yeth oc Bros., and the H.R.Mulford Company, of Phila-
delphia; Park Davis & Company, and the Frederick Stearns &
Company, of Detroit, Llich, ; the Searl & Hereth Company, of
Chicago, The pioneer manufacturer of druggists* balances, or
fine scales, was Pienry Troemmer, who came to this country from
iviarbury, Germany, in 1836, and two years later started business
in Philadelphia, Prior to this time, the scales which v/ere
required by druggists had been made to order by jewelers.
The enormous increase in the consumption of medicines in the
United States can well be indicated by the fact that, while the
population of this country from 1880 to I9I0 increased by 83,8%
I
the value of the patent medicines manufactured in the same
period increased 740.5%. \/hile in 1889, the total capital
invested in the drug grinding trade was but ;ii;358,000, That
amount increased nearly ten-fold to ^^2,838,000 in 1899, (see
schedule I). The capital invested in all branches of the drug
manufacturing industry amounted to ;i,;25,461 ,000, in 1889, while
it increased to $56,175,000, in 1899, (see schedule II ).
SCIiEDULE I
DRUG GRINDING
Year No. of
Establ'
;
V/ages
5(000)
'.Vage ii.,a-
rners-Av
Capital
(000)
kat .Cost
(000)
Value of
Prod. (000
1889 IS 75 148 538 192 437
1899 26 292 644 2838 5515 4308
Taken from- "The Biennial
Census of Manufacturers"
-I92I-
SCIIEDULE II
INDUSTRY- ALL BRANCHES
(patent medicines, etc.)
Year r'jo. of
Establ'
s
Viages
(000)
vv'age Ea-
rners -A"'
Capital
r (000)
L:at .Cost
(000)
Value of
Prod. (000)
1889
1899
3,089
2,154
4,297
6,910
10,485
19,028
25,461
56,173
27,740
31,949
47,910
88,791
Taken from-"The biennial
Census of I.Ianufacturers"
-I92I-
II
Effect : It is evident, from the above discussion, that
during this century there v/as a marked emphasis on production.
Marketing policies were negligible and progress along that
line unthought of until after the year 1880. The demand for
the product was there, the objective of the manufacturer was
to produce a supply sufficient to satisfy that demand. In the
last decade, however, they began to realize that their prod-
uction was outrunning the market, .^s a result, they became no
longer satisfied with their old and orthodox method of dist-
ribution, namely, from manufacturer to wholesaler, to retailer,
to consumer, but began searching for new outlets and for new
methods of disposing of their product. It became evident to
them that over-production resulted in large overhead and in-
ventory expenses.
Consequently, they began attacking the human element by
advertising their branded-goods through the retailer. They
attempted to evade the wholesaler by selling directly to those
retailers doing a large volume of business. They found that
mail-order houses, chain and department stores attained that
purpose very well, so the manufacturer began granting them
quantity discounts. Hence, the rise of chain, department and
nail order drug houses during the last decade of the nineteenth
century— at the expense of the wholesaler.
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to carry nany articles which were not strictly entitled to a
place upon the pages of the Pharmacopoeiae , In fact, this
feature of the drug trade has so greatly extended that refer-
ances to recent grice-lists issued by the prominent jobbing
houses show that there are now more than 5,700 articles in the
department of drugs, chemicals, oils, etc., and close to 8,000
items in the department of patent medicines. These figures
would undoubtedl:7 be doubled were you to add druggists* sundries
and "secret proprietory'' medicines.
In the late seventies, however, many new firms entered the
drug wholesaling field. This gave rise to a competitive con-
dition that became so sharp that concerns which had hitherto
been considered as prosperous houses found themselves unable
to iiiake a profit. ,ls a result, the li^astern druggists joined
forces v/ith the Vs/e stern wholesalers and formed the iNiational
Wholesale Druggists* Association, in 1882, This organization
appointed a comioittee to try to induce a system whereby such
competition would be eliminated, therebjr allov/ing all jobbers
concerned to make a profit on their sales, A system, now
knovm as the "rebate plan", v;as introduced. According to the
old method, such articles as patent medicines had been sold
on a very close margin, but this new plan v/as devised to give
the wholesale druggist an opportunity to obtain a fair profit
upon such preparations. Ey the adoption of the rebate plan,
therefore, the wholesaler consentecl to sign a contract by
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RETAIIiSR
;
As has previously been mentioned, the retailing pharm-
acist, in the period from I800-I850, became a producer as v/ell
as a distributor v;ith the introduction of hand machines for
the production of pills. He made his pills in small lots,
packaged them in his ovm branded boxes, then tried to sell them
at a profit, Hov/ever this condition v/as short-lived.
On July 8, 1870, the government of the United States gave
manufacturers sole rights to the production and sale of new
preparations formulated by them. With this right came into being
"trade names" and "patent rights". Almost immediately after
this preference was granted, people became so conspicuous for
their faith in the efficacy of that word "patent" that retailers
had to carry hundreds of such different medicines to satisfy
the calls of their customers for them. They could no longer
make the major portion of their own preparations but had to
carry in stock innumerable different items and brands of the
same vemedj, such as cough medicines and cod liver oils.
To attract business, retailers began advertising these now
well-knovm branded medicines at reduced prices. Keen compet-
ition resulted betv/een these cut-rate independents, a compet-
ition v/hich was gradual until 1880, but which grew at a rapid
pace thereafter. At first, the practise was to mark dovm only
branded goods whose standard prices were knovm to the people,
anticipating to make up the loss on other merchandise. But later
v/hen everyone began to follow the leader, some retailers began
II
I
•'i
J
cutting prices on the other merchandise also, as well as their
ovvn proprietary medicines. At that tirae, the retailer vi/as in
the habit of buying directly from wholesalers in small quan-
tities- after reducing prices, however, the more prosperous
pharmacist found that his volum.e had increased to such an ex-
tent that he could nov/ buy his fastest selling items directly
from the manufacturer, thus excluding the additional expense
incurred through the middleman. The manufacturer, in turn,
only too eager to increase his production and create a fast
turn-over, gave these retailers quantity discounts. This placed
the latter on the sane par as the wholesaler insofar as pur-
chasing power was concerned. These discounts, in turn, gave
the retailers power to reduce prices on their goods stiLl
further.
The more far-sighted business men of the tirae began to rec-
ognize the fact that most people looked for low prices rather
than service and began forming drug co-operative organizations
so as to get quantity discounts from the manufacturer, in orfier
to meet that prevalent desire of the consujaing public. Thus
v/e have the rise of co-operatives in this period, as a result
of the pric'^cutting policies of independents and the eagerness
of the manufacturers to sell in voluiae.
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DEVELOPIViaM' OF THE DRUG INDUSTRY —1900 -1957
Preface :
Inviev/ of the fact that in the course of these last 37
years the drug industry has developed into a very complicated
trade, it is essential that one should thoroughly understand
the various classes of drugs in order to appreciate more fully
the extent to v/hich the industry has grown. For that purpose,
the various classes of drugs will he enumerated, together with
their corresponding provisions as they are listed in the Tar-
iff Act of I9I3, They are as follows;
I) the natural and uncompounded drugs, chiefly of vegetable
origin, such as balsams, barks, berries and fruits of nuiaerous
plants. The drugs in either crude or advanced state are enum-
erated by nature or origin in the provisions of //^9, 27, 4-77,
2j Alkaloids, glucosides and other medicinals, usually of a
definite chemical character, and derived by manufacturing
processes from materials v/ithin the scope of class I (above )-
#5, 13, 18, 31, 47, 70, 584, 616,
3) i.iiscellaneous natural or roanufactured substances, such as
certain expressed and essential oils- # 4-3, 46 and 561,
4) Compounded medicinals and pharmaceutical preparations, con-
sisting of mixtures, extracts, tinctures, pills, etc., and
including the majority of proprietary medicinals, both alcoholic
and non-alcoholic, // 5, 16, 17, and 249,
5) Anti-toxins, serums, vaccines and other so-called biological
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products, chiefly of animal or bacterial origin, //400.
6) Organic and inorganic compounds used in medicines, such as
alcohol, chloroform, ether, Epsom Salts, Gluher Salts, etc.,
and the coal-tar and other complex chemical medicinals, (some-
times termed synthetics) . Many of these have predoDiinate uses
in chemical and technical industries, 7yI,8,I4,I5,I8,I9, 29,65-
67,I44,5I5,6I7, and 635,
It should he well understood that there is a close relat-
ionship between all the classes of drugs enumerated above.
It should also be kept in mind that recently raany articles
foreign to the trade have entered into the drug line, such as
chemicals, cosmetics, sundries, and various other articles
which have, in some cases, medicainal use, but which are used
chiefly for manufacturing or industrial purposes. As a res-
ult, statistics concerning the production, marketing and sale
of the "purely drug line" have, lunnj times, never been compiled,
but rather, the true figures have often been included v/ith those
of sundries and chemicals. An attempt will be made, however,
to break dovm and analjT'se these figures as accurately as possible
to give true data relative to the "purely drug line".
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Cultivation of Druf;s
:
Vi/orld trade in crude drugs is as ancient as commerce itself.
The superstitious materia medica of the past reached out into
unknov/n corners of the earth for unknown products v/hich der-
ived their chief value from the mystery of their origin. The
search for drugs and spices was not the least of the spurs that
led to the discovery of the r^ew Y/orld. Even now v;hen scientific
tests have discarded hosts of valueless medicinals, there is
hardly a country which does not furnish somemedicinal supply.
In former times, the drug trade of the world was centered in
Hamburg, Germany, and this port controlled largely the cominerce
in iNiorthern Europe and ijorthern Asia. Triesta v/as an important
port in the in the drug trade for Southern Europe and i-jorthern Af
rica, while India served as a center for Occidental medicinals.
Today, London and Marseilles are centers for their respective coun
tries, and has now taken in large part the former preeminence
of Hamburg, i\[ew York has become one of the great ports for
American import and export trade, and if its importance attained
inthe V/orld V/ar continues, it appears very probable that soon
Nev/ York will overshadow in importance all foreign ports.
Crude botanicals are consumed in various ways. Many such
drugs, which are important in medicine, have or predom-
inate use in all connections; for example, licorice is largely
used for flavoring plug tobacco, and camphor in the manufacture
of celluloid. Considerable quantities of certain drugs, such

as sanotin, are used in veterinary medicines or stock feeds.
The chief channel of consumption for the crude botanical drugs
today, however, is in the preparation of medicines for the treat
ment of huinan disease.
Manj'' important drugs, such as opium, cora leaves, cinchona,
nux vomica, belladonna and ipseac, ov/e their therapeutic val-
ue to the alkaloids v/hich they contain. The purification of
these alkaloids forms an important branch of the drug industry
in which Germany, before the war, had shovm sone preeminence.
The United States, England, France, Holland, Java, Japan and
Switzerland also have well developed industries along that
line. However, large scale domestic production is limited to
cinchona and opium alkaloids, and to cocaine, strychnine, caff-
eine, emetine and hydrastine.
Two general channels of consumption of drug products for
hitman medicinal use may be indicated, although in some instan-
ces there is no clear line of demarcation: (I) Prescriptive
medicine, in v/hich drugs are prescribed and used under the
supervision of a physician, and (2) the so-called "patent or
proprietary medicines largely used for self -medication. The
composition, especially the percentage content of patent med-
icine, is rarely made known except when required by law. Ex-
ceptions may be cited in the class knovm as **ethical propriet-
aries", v/hose formulae are made known to physicians, to whom
they are chiefly advertised. The use of proprietary mixtures
containing narcotics, whether so labeled or not, has been

proven to result in numerous cases of drug addiction. Const-
ant supervision is also needed today to guard against intox-
icants masquerading as "proprietary medicines".
In the manufacturing of medicinals, the cost of crude drugs,
ranging widely as it does from a fev/ cents to less than one-
one hundreth of a cent per medicinal dose, is usually iEmiaterial
as compared v/ith the cost of solvents, (especially alcohol),
labor, manufacturing processes, advertising and other overhead
expenses. The actual cost of an available crude drug has comp-
aratively little effect on its use as legitimate medicines,
which is, therefore, unlikely to be affected by a rate of im-
port duty com.parable v/ith those of centuries past. The choice
and amount of drugs used in secret and proprietary medicines,
on the other hand, is more apt to be detected by comparable
cost. I.aany drugs, notably those of the bitter, "tonic", or
"blood purifier" types have been largely used in the manuf-
acture of proprietary compounds of the '* pure vegetable product"
type, whose actual effect depended in many cases on the alcohol
used and the amount of advertising. The sale of such nostrums
has been considerably curtailed by the Food and Drugs Act *
with the Volstead Prohibition Act, together with the various
postal lav/s.
In past tariff acts concerning crude botanical drugs, it
has been the general policy of Congeess to maintain differentials
* c.f. Appendix or Discussion of Legislation

between crude drugs, ground such as alkaloids and compounded
medicines.
Incidently, grinding is usually the first step in the prep-
aration of raedicines. In the United Jtates today, this process
is practised both by firn].s v^hich carry on no further manufac-
turing and by manufacturers of alkaloids and medic inals, v/hile
the tariff differential was presumably established for the
benefit of the drug grinding industry, its additional effect
in hindering imports of products liable to sophistication must
not be overlooked. Adulteration in ground drugs is very diff-
icult to detect, and this^ as v/ell as the tariff differential,
has tended to develop in the trade a preference for the crude
and unground products. The present differential of ten per
cent "ad valorem" is practically prohibitive of the entry of
expensive drugs (ground) but would not be calculated to keep
out cheaper materials.
Todajr, it is not always easy to differentiate between the
crude and the advanced product. In paragraph 4-77* of the free
list, it was provided for " natural and uncom.pounded drugs in
a crude state, not advanced in condition or value by shreddings
grinding, shipping, crushing or any other process or treat-
m.ent bej^-ond that essential to the proper packing of the drugs,
and the prevention of decay or deterioration pending manufac-
ture". This does not require the drug to be in its crudest
* Tariff Act of I9I3,
i
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state of occurrence or to be in initial process or manipul-
ation in order to "be classified as an item whose value has
not been advanced. For example, the Court of Customs Appeal
has held that gum resin reclaimed from turpentine, dirt, or
leaves or insects had not been advanced in value or condition*.
The differential between the crude and ground products is
not maintained in the case of crude drugs v/hich are specif-
ically mentioned either on the dubitable list or on the free
list. Specific ennumeration permits the entry of crude and
advanced drugs at the sane rate. Thus the provisions for acon-
ite, ipseac, jalap, nux vomica, salep, etc., include the art-
icles in any form or condition under the respective names. Too,
the mention of certain drugs appears to be traditional only;
^rhey are today of little or no medicinal or commercial impor-
tance and might well be omitted. No imports of Balm of Gilead
and of salap have been reported in recent years, but such
drugs as burgundy pitch, cocculus indicus, dandelion and marsh-
mellow roots are quite important. As in the case of articles
mentioned above, such omission, under a lav/ otherwise similar
to the present one, would probably not alter the actual income
status of future imports- should any be recieved.
For tariff consideration, crude botanical drugs may be
divided into three classes:
I) Exotic drugs- not commercially producible in the UnitedStates,
* U, S. V. Sheldon, 2 ct. Gust, Appeals, 485, 490 & 492.

2) Exotic drugs-whose production in this country has been
carried on only under v/ar conditions ,
3) Indigenous drugs- not produced to any important extent
elsev/here than in the united States,
The last class presents no tariff problems since there are
no imports. In the tariff act of I9I3, several largely imported
and valuable exotic drugs were singled out for specific tax.
As those have not been commercially producible in the United
States, except at a high cost, the raising of revenue may be
presur^ed to be the sole reason . The duty on those articles
ranges from (on gentian) to lOc^ per pound (on ergot).
The annual revenue from an individual drug varies from a
few dollars to over a million dollars ( Revenue collected on
crude opium in I9I5 was $ 1,059,013,), Import statistics in-
dicate that the rate of duty has little or no effect on the
voliune of imports, and a consideration of the actual imposition
per medicinal dose indicates no serious burden on individual
consuiaers. The prices of different commodities vary greatly,
but four dollars a pound may be taken as a limit which is
rarely passed by a crude drug- a pound represents from 250-
7000 medicinal doses.
In the case of drugs largely used for the manufacture of
alkaloids, a rate sufficient to preserve the approximate equi-
valence between the crude drug and its equivalent in alkaloid,
if deemed advisable, could be worked out separately for each
article, A duty based on the cost of manufacturing would, how-
I*
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ever, have to be determined by separate inquiry since these
costs Y8.Ty considerably v/ith different products.
It may be said that crude drug cultivation, frori a cornnex-
cial or agricultural vie\vpoint, is a relatively unimportant
industry in the United States, because of our climatic and
labor conditions, v/hich has made its production practically
impossible. Cultivation of botanical drugs requires a high
degree of specialized agricultural and technical skill and
experience, valuable land, some special appliances, and a class
of labor v/hich is much more expensive here than in Europe and
Japan, where botanicals are gathered by the cheapest of peasant
labor- old men, v/orr.en and children. The scope of the industry
is further limited by the exacting climate and the soil require-
ments of most of the crops, by liability to insects and also
disease damage, and by a comparatively small demand, which in
most cases is limited by necessity and cannot be stimulated
as can the demand for foodstuffs and manufactured products.
Even v/hen, during the World V/ar, the demands for such
products rose to unprecedented heights, it proved to be an
unprofitable venture for the American agriculturist to plant
certain lines of crude botanicals. Prior to I9I4, experim-
ental cultivation of a number of crude drugs had been carried
on for a number of years by the United States Departaient of
Agriculture, colleges of pharmacy, agricultural experiment
stations, and by a few drug firms. Upon the outbreak of the
war and the partial cutting off of imported SLipplies, the prices
iI
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of crude drugs rose rapidly, further accelerated by Army
demands. The influenza epidemic in the United States and
abroad called for enormous quantities of drugs. As a result,
drug cultivation attracted considerable popular interest; and
efforts were made at once to produce several indispensable
botanicals which were apparently suited to ^'arxerican climatic
conditions. Considerable success has been reported with two
important medicinals, belladonna and digitalis; and also v/ith
cannabis indica, the drug obtained from Indian Kemp, Henbone,
stramonium, valerian, and oevent wormseed, all important drugs,
have been cultivated with varying success. The cultivation of
others was undertaken on an experimental scale. Hov/evcr, the
fact that all nations stimulated its collection at this time,
I9I4-I9I8, resulted in an overproduction of some drugs v/hich
in most cases caused a loss to grov;ers, due to the consequent
drop in price.
The cultivation of thess crops in the future is not likely
to be extensive. It may never become a major trade in itself
due to the fact that successful crops are not possible except
in the hands of specialists having adequate equipment for the
proper curing of the crop and possessing special knovirledge
of the botanical and chemical characteristics of the drug
plants. In mRny cases, the quality of the product must be con-
trolled by chemical analysis or animal experimentation, .al-
though these exacting requirements have been met in the case
of certain indispensable drugs in the past, v/hen prices were

high, the renewal of lov/-priced imported supplies has prac-
tically anhilated our domestic industry, even though Amer-
ican grown drugs, in general, are more carefully produced,
better standardized and of higher commercial value than are
the imports. Further renev/ed attempts to cultivate drugs in
the future is possible, yet not probable.
IV
j
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Maniifacturing:
With competition becoming more intense at this stage, and
with new processes of production constantly being developed,
the manufacturing phase of the industry has become subdivided
into various branches, chiefly comprised of; I) the manufact-
uring of druggists' prepartions, 2) the ro.anufacturing of
patent medicines and compounds, 3) the manufacturing of perfum-
ery and cosmetics, 4) disti at ion and refining of natural and
essential oils, and 5) drug grinding. Druggists preparations
are products used mainly by pharmacists in compounding medic-
ines to be dispensed upon physicians' prescriptions or orders.
Patent medicines and compounds are those sold under the prot-
ection of patents, copyrights, or trade marks, or else prep-
ared according to secret formulae, which includes medicines
of a proprietary character, not necessarily patented, and
boiler compounds. Perfumery and cosmetics include such articles
as perfume, toilet water, toilet preparation, cold cream, etc..
Today, the manufacturer is no longer in a position to just
produce his articles and turn them over to a wholesaler for
distribution. He now realizes that, although the demand for
such products still exists, the supply has increased with prop-
ortionately greater velocity than the demand. He realizes also
that he must now create a demand for HIS product becuse he
knows that his competitions are producing the same article.
He can do this either through a low selling price, advertising,
or by producing a distinctively superior product.

-44-
To be able to sell the goods at a lov/er price than his
competitors, it was necessary for hiia to be capable of prod-
ucing and marketing these items at a very low cost. In order
to fulfill this need, manufacturers now standardize their
methods as well as their products, attempt to secure the best
and most efficient v/orkers, maintain a cost accounting system
and try to keep their overhead expenses at the lov/est possible
point. Probably the most stress is laid upon standardization.
When the crude material is recieved froiix the bulk stores, a
sample is immediately sent to the analytical department for
analysis and approval. The quality must be exa^ftly as specified
in the purchase order, and although the foreman of the bulk
department may know that the specifications have been met,
still the raw material must go through a process of analysis.
If apijroved, these materials go into i)rocess and once the
batch is finished, the product itself is sent to the anal-
ytical department to be tested with regard to quality,*
At the present time, it is a rule of most of the outstan-
ding manufacturers that every individual who has anything to
do with the manufacturing process must be a registered pharm-
acist. The master planning, i.e., outlining the v/ork and pro-
cesses, in most manufacturing industries, is done by the eng-
ineering department, but in this particular trade this dept-
artment is of minor importance because it would be impossible
* Information gathered from field trip to United Drug Co.,
Gr. B-IO, 1936.
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for an engineer to deterndne what could and v/hat could not
be manufactured- the only use that is made of this department
is to determine the most productive lay-out within the manuf-
acturing department. Consequently, the need of some form of
planning experts has given rise to the formation of a Formula
Coramittee which is composed of six members. A doctor of med-
icine usually presides as chairman of the coirjnittee while
the other five members include the chief chemist, his assis-
tant, the drug buyer, the man in charge of the technical
literature and the head of the laboratory department. The
duties of this committee are to investigate any formula which
may have been presented to the company by a stockholder and
to write formulae for new lines which the company would like
to add to their existing standard line. Should a new formula
be accepted and approved, a sam.jjle batch is made by the members
of the comiaittee and tested as to quality and effectiveness.
If the drug is proven satisfactory, the department then drav/s
up standard specifications stating the quantity it would be
necessary to make at one time in the process of manufacture
and the nev/ equipment needed to produce it.
Once the m_anufacturing process is completed, manufacturers,
with the aid of trade-marks, trade names, etc., package the
product according to certain standard rules. This has proven
to be of great importance inasmuch as the primary/ purpose of
trade -marks and standard packaging is for identification. For
example, the name i'orhans', the distinctive v/ay the name is
written, the color and design of the tube and carton, and the
ii
phrase " for the Gmns" on a package of I'orhans' toothpaste
identify this merchandise and set it apart froi:i all other
toothpastes. Such trade-marks are chosen v/ith great care, due
to the fact that they must obtain favorable and widespread
recognition to be successful. In recent years, there has been
a tendency to package the product in fancy and elaborate
containers. In fact, conpet ition in package design for per-
fumes, for example, has resulted in the introduction of a very
definite style element. Each season, manufacturers in this line
introduce new designs, but the v/ise ones are careful to retain
not only the undeniable style appeal of the new package and
design, but also the ready recognition of the long established
trade-marks and other means of identification.
There is no doubt but that standard packaging, as described
above, is an advertising factor in itself. But aside from
this, the more successful manufacturers have used other media
for sales promotion, "he follov/ing are the chief methods used
to attain this end: I) periodical advertising- through prof-
essional and trade journals, li) publicity- by radio, news-
paper, street car and bill-board advertising, 3) promotion by
mail- usually done in periodicals, 4) sampling- divided into
three groups; professional, trade and general, 5) displays and
dem.onstrat ions- by furnishing the display material to the ret-
ail druggist.
As a means of attempting to lower his overhead cost, the
manufacturer has devised means of increasing his turn-over, thus
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reducing his inventory cost per unit. To do this, quantity-
discounts were given to any distributor, whether wholesaler
or retailer. This encouraged the distributor to buy in larger
lots, giving him, in turn, an opportunity to sell to the ret-
ailer or consu2r).er, respectively, at a lower price. Such a prac-
tice resulted the formation of drug rautuals and co-operatives.
Schedule III, page 38, sui:i2iiarizes the statistics concern-
ing the drug manufacturing industry for each census year beg-
inning with the earliest for v/hich comparable data are avail-
able. The manufacturing industry as a whole shows an uninter-
upted but irregular growth from 1889- I9I9, but for I92I the
figures indicate a decline. If, however, the statistics for
I92I are compared v/ith those of I9I4, the last preceding nor-
mal year, pronound increase appears, both for the average
number of wage earners and value of the products. In making
comparisons of the financial items for one census year with
those of another, particularly in comparing I92I or I9I9 with
earlier years, the effect of changes in prices and in wages
must be taken into consideration. For this reason, the average
number of earners is a better standard for measuring the growth
of the industry rather than the value of products. It should
be kept in mind that the difference in prices between the years
I9I9 and I92I was largely, if not wholly, due to the termination
of the V/orld IVar and the consequent termination of an excessive
demand for medicinals and all forms of drugs and drug prod-
ucts.
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SCHEDULE III (a)
LIAMJFACTUP.ING IIipUSTHY- ALL BRi\I^^CHES
(patent medicines, etc
.
)
Year No . of
Hi b 0a u JL fc
V/ages
1 ODD ]
Vvage Ea-
Pile I s — . \.
V
Capital Mat .Cost
\\J\JU j
Value of
j-K>/^^ / nnn ^X roQ
•
{ uuu j
1904 2,777 7,914 20,472 75,607 59,495 77,941
1909 5,642 9,897 22,895 99,942 50,576 91,565
I9I4 5,815 12,710 25,502 127,722 66,340 101,052
I9I9 5,560 29,894 58,417 278,298 170,105 216,264
I92I 2, 266 50,979 50,476 * 152,158 197,979
1925 2,217 55,202 54,080 * 159,802 257,077
1925 2 , 245 55,206 55,201 * 167,786 504,708
1927 2,560 59,574 55,672 * 177,905 571,892
1929 2,766 44,996 40,251 * 191,844 440,281
I95I 2,052 54,756 54,987 * 166,769 557,962
1955 1,866 28,124 50,658 * 115,079 266,891
* Data not available. Taken from; " The Biennial
Census of Manufacturers"
- 1929 -
SCPIEDULE III (b)
-DRUG- G-RINDING-
Year No. of
Establ '
£
lYages
(000)
Wage Ea-
rners-Av
Capital
(000)
Mat .Cost
(000)
Value of
Prod. (000)
1904 27 483 981 4,991 5,024 5,460
1 9 21 28 1,005 1,215 21,991 11,556 16,958
Taken frora; "The Biennial
Census of x.anufacturers"
-1929-
II
I
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WAR CONDITIONS-- ( I9I4-I9I8)
Before the World Vmr, the United States v;as the largest
producer of chemical and pharmaceutical products in the v/orld,
Germany occupying second place. The total production was estim-
ated at i~^2f'582. millions of dollars, (10 billions gold marks).
Of this total, the United States manufactured opSIO millions of
dollars or 34->o of the v/orld 's supply while Germany produced
i#57I millions, or 24%. By 1925, hov/ever, the world production
rose to an estimated value of $4,288 millions with the United
States still occupying first place with an estimated value of
$2,000 millions and Germany at fj^VIb millions. The share of the
United States in the v/orld total had increased to 47'/o, v;hile
that of Germany had decreased to 17^0. The latter' s relative
decline v/as due largely to the more rapid developnent of chem-
ical and drug production in numerous countries that before I9I4
were Germany's best customers, but v/ere cut off from their
sources of supply during the four years or the war.
A special and very important factor that contributed to the
rapid development of the /unerican drug and chemical industry,
as v/ell as that of the French and British, after the war, was
the confiscation of German patents during this time and their
acquisition by our domestic industries, a striking example of
this may be had if we consider the case of Bayer's Aspirins.
This company was originally ovmed by the 1. G. Farbenindustrie
,
of Germany, but at the beginning of the war v;as seized by the
United States -ilien Property Custodian, (at the time iv.r. Francis
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P. Gavan) , and later sold by the government to the Sterling
CoLipany in I9I9, Still another exainple would be the the Ger-
man aniline-dye industry. More than SOyo of the world production
of the aniline- dyes, in 1913, \ms supplied by Germany. Ten
years later, Germany produced but 46;^ of the v/orld total, v/hich
total had remained practically stationary during that time.
Germany also lost considerable ground as a producer of sulf-
uric acid and of superphosphate, due to the restrictions imposed
upon Germany by the Treaty of Versailles,
The dom.estic market in laedicinals was disturbed by v/ar con-
ditions to an unusual, if not unique, degree. This was part-
icularly due to the fact that all lines of drug preparations
in the United States draw their materials from remote and
detached sources. Our drug and pharmaceutical trade is pecul-
iarly geographic. It has been stated that a single prescription
may even call upon the resources of five continents in the
filling, .^s a result, this industry, probably to a greater
degree than any other, was greatly affected by the severing
of international relationships existing prior to the war.
The trade, especially that involving botanicals and their
derivatives, was peculiarly unprepared for the conditions
resulting from the outbreak of the European conflict. Long
continued droughts had affected i^uropean crops. Added to this
was the business inertia of an inaugural year and the uncer-
tainties of the tariff revisions and banking reforms. The Mex-
ican trouble and the continual political disturbances in the
I
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Balkan States, with accompanying fears of international comp-
lications, had all operated to keep prices up and discourage
buying beyond immediate needs. Jar was declared in the trough
of the buying season as prospective purchasers were awaiting
maturing crops and better buying terms. Too, the principle
ports from v/hich a large percentage of our raw materials were
bought, nam.ely, Trieste and Ivjarseilles , were cut off. As an
immediate result, all drug cultivation in Europe ceased, with
the exceptions of Italy, Spain, Plolland and Denmark.
Consequently, during tlie first part of August, 1914, con-
suraers of crude drugs began to buy all needed materials as
extensively as their accounts and the supply of materials
would permit. During the latter part of the month, however,
moderate shipments of German goods, arriving via Holland,
resulted in a general recession of prices of rf.o.ny European
commodities which continued into September, as price conditions
drev/ out unexpected stocks from neutral countries and confid-
ence was restored with the growing opinion that the v/ar would
be short. Following this short recession, most merchandise
in this group rose rapidly in price and earlj;" acute condit-
ions were relieved in I9IG and I 917 by various market influ-
ences, the principal of which was the constant and increasing
development of x^jnerican manufacturing.
Therefore, in summarizing, v/e have the following influences
affecting drug prices during the war period; (I) the block-
ade of Germ.an ports, (2) a "wild mxarket" v/ith resulting spec-
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ulation in existing drug stocks, (3) withdrawal of maritime
coiiu lerce to v/ar materials, (4) shipping terminal facilities
couping rates, (5) labor division to military ends and, (6)
government export restrictions on many forms of drugs and
pharmaceuticals
.
The said export restrictions v/ere very stringent at this
time. For instance, American export control limited shipments
of aspirins to one hundred pounds or less after October c;5,
I9I7. The Wood Chemical Section of the V/ar Industries Board
in I9I9 limited the aFj.ount of acetic anhydride to be used in
the manufacture of acetylsalicylic acid because of the need
of such a chemical for airplane purposes, which restrictions,
accelerated by an epidemic of influenza, caused prices to
rise further, Bayer's aspirins, for example, which sold at
thirty cents per ounce in I9I3, was advanced in price to forty-
five centvS in August of the year I9I4, and to sixty cents in
September of the year 1915, at v/hich level it remained for
some time. This is but one examxple of the v/ar's influence on
the trend of drug and pharmaceutical prices. The following
schedule (p. 53) will show the price trend of drugs as compared
with the general price level of all commodities during the
period of the World V/ar, I9I4-I9IS.

(V/eighted Index Number of Prices-
Av. Quoted Prices, July I9I3- June I9I4)
Taken from, "The United States Bureau of Domestic and
Foreign Commerce- (department of Comm.)"
Series 36-57 , "Prices during the .Jorld
V/ar,
"
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In spite of these restricting laws and of the difficulties
that ilinerican drug raanufacturers had in obtaining rav/ materials,
figures show a constant grov/th of the industry during this
period. In I9I4, 3,815 establishiaents , v/ith a production val-
uation of >ii;iOI,032,374, were listed in the Biennial Census
of Iv.anufacturers (I92I). This represented an increased value
of 22.3>c; since 1909 and of 214.1^'^ over that of 1889. The value
of patented medicines, compounds, and subsidiary products
accounted for about three -fifths of the entire value, repres-
ented by the industries engaged in such raanufacturing of med-
icinals, drug preparations, perfumery and cosmetics. Of the
above value, ^1)83,455,264, or 83.5>o, represents strictly med-
icinal articles- the remainder representing fire-extinguishing
compounds, insectides, etc.. The value of druggists' prepar-
ations, v/hich included materials for prescription medicines,
is given at §49,375,739 for I9I4. IVhile comparative statistics
are lacking, it may be safely assumed that .Imerica now leads
the world in manufacturing medicinals.
However, although the drug manufacturing industry, as a
whole, went into a recession after the war (I9I9), the manuf-
acturers of perfumery and cosmetics showed an increase in
production from I9I9-I92I and an uninterrupted growth as meas-
ured by the average number of v/orkers. Moreover, between
1909 and I9I9, the rates of increase in the average nui-iber
of v/age earners, together with the value of the product, for
the perfuLiery and cosmetics branch of the industry were much
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higher than the corresponding rates for any of the other
branches
.
As we move forward to the year 1929*, v/e find that the
volume of the drug trade in the United States can be but ap-
proximately estiiiated as there v/as a tendency at the time
to combine all data relative to the production of medicinals
and pharmaceuticals with "cheiriical production". The most ac-
curate survey could be made only with the aid of the figures
recorded by the Census of Manufacturers (I9Jd9), which broke
down these combined figures and attempted to gather separate
statistics relating to the manufacturing of "druggists' prep-
arations", "patent and proprietary medicines" and " perfumery
and cosmetics". Reports were recieved by S,I79 establishments
whose combined products were valued at ^;,;501 , 976 ,000. Of this
total number of establishments, 496 were located in uev/ York,
278 in Illinois, 171 in Pennsylvania, 152 in Ohio, 155 in
Missouri, 135 in California, lOI in Rew Jersey, 95 in i..ass-
achusetts, 56 in lov/a, 60 in Michigan, 59 in Indiana, and the
remainder scattered among thirty other states.
The manufacturing of druggists' preparations v/as represented
by 375 establishments with products valued at '^96,715,000.
Liquid preparations, such as tinctures, fluid extracts and
medicinal syrups, were valued at .,^31,217,000; and of pills,
tablets, powders, etc., at ^^34,675,000, The manufacturing of
* The year 1929 was chosen because; (I) Base for index nos,
is usually this year, (2) It was a peak year, (3) In this
year there ocarred great geographic distribution of plants.
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alkaloids and their derivatives, such as cocaine, codein,
morphine, quinine and strychnine, was reported by 26 establish-
ments, with products valued at over 5,000,000 dollars. The
production of synthetic iviedicinals preparations, such as acet-
anilid, saccharin, metalalicylate
,
etc., v/as included in a nev/
classification of "liquid preparations", tinctures, etc., in
which about 300 establishjuents engaged, with products valued
at over thirty million dollars. Pharmaceutical metals and
their salts, bromides, citrates, etc., engaged about 27 plants
with products valued at over one million dollars. Serums,
vaccines, etc., occupied about 57 factories, yeilding over
ten million dollars in finished products.
The manufacturing of patent and proprietary medicines,
including ammonia, insectides, fire extinguishers, etc., v/as
carried on by about 875 concerns for the medicine trade, v/ith
products valued at i^pI70 , 000 , 000 , and by about 1,200 for the
commercial compounds, with an output worth $72,000,000, The
larger part of the division of the drug manufacturing trade
was carried on in New York State, v/ith over 200 establishments
in Illinois, 100 in Pennsylvania, and 90 each in Missouri
and Ohio.
In 1929, perfumery and cosmetics including cologne and
toilet waters, face powders, cold cream, v/ere m.ade by 803
establishments, their output valued at $^207,461,000, These -
figures shov/ an advance of about 50)3 in the number of plants
over 1919, but an increase of more than 700^/:. in the value of
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the products manufactured. Lev/ York State led in this branch
of manufacturing v/ith over 300 establishments, followed by
Illinois with 100, Pennsylvania with 50, and with 45 in Cal-
ifornia.
..nother branch of the drug manufacturing trade is the
distilling and refining of natural essential oils, such as
wintergreen, peppermint, etc., and of witch-hazel extracts.
In the census of manufacturers for 1927, none of the small
establishments v/hose yearly output was valued at less than
$5,000 was ennui;ierated l in I9I9, the number of such small
concerns in operation was but o2)
. In 1927, there v/ere but
14 of the larger establishiiients operating, v/ith a total of
169 workers employed. 'Jhe total value of the output was
#4,642,000- of this sum, ^3,427,000 was paid for raw materials.
Incidently, this phase of the manufacturing trade is largely
seasonal, most of the v/ork being done in /.ugust and September,
Today, such distillers and refiners are distributed as follov/s;
Indiana, Michigan and Kev/ Jersey each have three plants, Conn-
ecticut has tv/o, and LTev; York, Nev/ Hampshire and California
each have one.
As we move on into 1933, we find the manufacturing industry
receding. The total nui'iber of e stabli sliment s , in all branches,
dropped from 2,766 in 1929 to 1,866 in 1933. The average
nuE.ber of v/age earners decreased by 25'/v,, while the value of
the products manufactured diminished by almost 100%, (c.f.
schedule III). It should be understood, hov/ever ,that in 1933
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we v;Gre in a depression which crippled all industries, as
well as this one.
Recent attempts has been made retailers to enter the man-
ufacturing field. Very few have proven to he successful, and,
in fact, those who have made a success of it, were formerly
large chains, Kven many of these great chains have been rel-
uctant to enter this field, due to the fact that great expenses
are involved in creating a demand and acceptance for the products
in question. They are generally not in a position to purchase
the most economical quantities of rav/ materials, nor main-
tain a thoroughly qualified staff of specialists to assist
in the designing, creation and development of the merchandise.
Many are unwilling to gamble on the acceptability of their
product by the consuirdng public, which may be hindered by the
diversion of too much sales effort from the established brands.
They realize that it takes a long time to develop a well-
balanced product in order to insure repeat sales, and, there-
fore would rather handle established items at a slightly higher
cost.
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Marketing :
Schedule V, page 60, is an attempt to sliov/ and indicate
graphically the various means by v/hich drugs and drug merch-
andise can, and does, move from manufacturer to consumers.
Aggressive distributors, in their effort to form what, for
them, is the most effective combination of selling agencies,
yeilding maximum present and potential profits, constantly
test the innumerable variations possible. However, it should
be understood that no generalization can be made as to which
one is best- that is a matter which must be determined for
each product that is to be distributed.
The mere fact that a large nuiiber of such channels is avail-
able does not mean necessarily that efforts should be made to
market the product through all of them. If, let us say, a
producer of medicinals sells the greater percentage of his
output to wholesale druggists and retail drug stores and then
attempts to sell these same products to wholesale and retail
grocers, he would certainly destroy the 'goodv/ill and interest
of the distributors through which he sells the bulk of his
production. Likewise, a manufacturer v;ould not find his mer-
chandise cordially recieved by wholesale and retail druggists
if he attempted to sell also to physicians' supply houses.
Therefore, it is evident that great care should be taken
by a producer in the selection of a policy regarding the types
of agencies he will chose for the distribution of his prod-
uct .

SCHEDULE V
DISTRIBUTION CliAmiELS IN THE DRUG INDUSTRY
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WHOLESALERS
;
One of the results, as we have noted, of the Industrial
Revolution, was the geographic division of labor, 'i'he problem
of marketing is to get the products of one area to that of
another group which has specialized in the manufacture of
soir.e other product and has none, or very little, of the goods
of the first area. The aim of marketing should be to get the
goods from the producer to the consuiner with the least possible
additional expense consistent with sales service. The function
of producing goods is to give "form" utility to them, v/hile
the marketing is to give primarily the "time" and "place"
utility.
There can be no question in the drug industry but that the
wholesaler, just as much as the retailer, supplies the latter
utility today. I"is stock is in the vicinity of 50,000 differ-
ent articles, some fro:.: all parts of the world. This fact in
itself is sufficient to explain the existence of the drug
wholesaler as an important factor in the distribution of drug
products, since it v/ould be irpractical for a retail druggist
to attempt to buy every item in his stock directly from the
manufacturer because of the fact that the cost of such a prac-
tice v/ould be prohibitive both to the retailer and the producer.
The cost of distributing various classes of merchandise at
wholesale in the drug trade shows surprising differences. Nat-
uralljT-, costs are higher on items of large bulk, lov; value,
and small and slow sale, especially if they are bought by ret-
(I
ailers in snail quantities. Contrarily, the lowest costs,
proportionately, are on it ens of snail bulk, high value, and
fast* and large sale, especially when they are bought by ret
ailers in large quantities.
SCHEDULE VI
Expense
Ratio
WHOLESALERS* L'^GIN, EXPENSE RATIO
AND STOCK-TURN
(drug trade) Profit
Ratio
30
20
10
0
TOTAL EXPENSE MARGIN PROFIT
t?0^ Stock-turn less than 4,.5 tines.
k^'j- 3tock-turn 4.5 to 6.9 tines.
lifMKl- -itock-turn 7.0 times and over.
Taken from; Report IV of
"The National Distribution
Conference", Cham, of Comm.
1I
1
m
In the course of the past two decades, many wholesalers
have recognized the importance of the above principles, iilthough
it is true that they have actually carried a full line of mer-
chandise in stock, they have retained, as liiuch as possible, a
larger inventory in fast selling, large voluiue items. For example,
of a total stock composed of 50,000 different items, four items,
including a total of fourteen sizes and styles, made up 3 and one
third percent of the total sales of 118 wholesale druggists in
1928,* The fact that their volume of business was concentrated
on but a few items greatly influenced numerous full-line service
wholesalers to develop important and profitable laboratories
for the manufacture of these products.
As a general rule, very little additional expense is incurred
by the v/holesaler in the production of these items. If the heads
of the v/holesale house are not pharmacists themselves, there are
certain to be num.crous such men among their employees. Practically
all of the wholesale druggists' customers are pharmacists. Thus
is created a situation in which the seller and buyer are acquain-
ted by training and inclination, at least to some degree, with
the technical processes of pharmaceutical manufacturing- v/hich
technical service can be had by the wholesaler at very little
cost
.
Other contributing factors that have led to a development
along this line have been; (I) the fact that many staple drugs
* l\Iational j^holesale Druggist .Lssociation- Bulletin no. 2
by >i. J. Ostlund.
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and chemicals are bought by wholesalers in containers of sizes
that necessitate repacking in smaller containers for delivery
to retailiiig customers. This means, for instance, the transfer
of medicated alcohol from drums to one- or five -gallon containers.
From this unavoidable repacking, it is but a step further to
packing rubbing-alcohol in pint and quart bottles and labeling
it vv'ith a private brand. A sales promotion plan may logically
follow, (S) the increasing tendency of retail druggists to buy,
ready made and ready packaged, many items which formerly were
made and put up in drug stores.
However, the successful promotion of identified specialties
by the wholesaler depends upon his recognition that this prom-
otion is a group of problems entirely separate from, those incident
to the operation of a wholesale drug house. This usually means
the development of a separate organization for this purpose. On
the other hand, the supplying of the demand Vv'hich exists for a
variety'' of unidentified staple prescription and home rem.edies is
a service that the wholesale druggist can usually perform econ-
omically and profitably v/ith very little special facilities. In
the class are such item.s as gur.i camphor, sweet spirits of nitre,
camphorated oil, fluid extract of cascara, and so on through
the list of readily acceptal)le items.
One of the r.ost frequently considered problems in the v/hole-
sale distribution of drug products, and a problem that is of
interest to both manufacturers and wholesalers toda^?", is the att-
itude of wholesalers tov^ard national brands. This attitude may be
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range fron active opposition through coiriplete indifference up
to active, enthusiastic, and effective co-operation.
Opposition to a particular national brand may result from griev-
ances of the wholesaler concerning the discounts allov/ed or prop-
osed, or from the manufacturer's direct solicitation among retailers
of orders to he filled by v;holesalers , which orders are of a
size and kind that cannot be handled profitably. These complaints
have sometimes led many wholesalers to actually refuse to handle
the merchandise, even though a manufacturer of a product that
is v/idely accepted by consuraers is not going to greatly affected
by such an attitude.
Frequently, comiplaints by wholesalers concerning discounts are
often justified. At one tir.e, the discounts allowed to wholesale
druggists by m^anufacturers ra.ngeQ from 10-20% of the price to
retailers, v/ith an additional 2% for cash, "while the actual cost
of doing business in a full-line drug house was 12-15% of sales,
or about 92% of the wholesaler's margin of gross profit ( see
schedule VII, page 66), Aside from this, the wholesaler found
that a considerable expense was incurred in trying to get the 2^
discount for cash. Under competitive conditions, the middleman
found that a policy of credit and collection was expensive, as
well as necessary. This was a matter v/here extended terms of pay-
ment from the retailer imiposed an unwarranted burden on him,
slowing up his turn-over of capital, increasing his investPxent
charges and thus adding to the cost of doing business. Because
his working capital was tied up in his recievables, he had to

-66-
SCHEDULE VII
DISTRIBUTION OF V/HOLESALERS' GROSS PROFIT
Taken from- "National Distrib-
ution Conference"; Ch. of
Comm., Report IV.
constantly borrov/ money from banks in order to recieve the
discount, as v/ell as to finance his customers. Hov/ever, prac-
tically all manufacturers, at the time this complaint v/as
made, agreed to raise their discounts to fifteen or sixteen
and tv/o-third percent, v/hile others, in an effort to obtain
preferential treatment for their products, offered discounts
to wholesalers as high as twenty or even twenty-five percent,
with the usual cash discounts in addition.
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V/hile net profits from the sale of a particular line of
merchandise in the wholesale trade are determined by three
factors, naraely, the volurae of business, the rapidity of
turn-over and the discount available, it would appear that
larger net net profits are obtainable if the discount is, let
us say, 2579 instead of 5%, This is not always the case. It is
a fact that some merchandise on which there is but 5>'o discount
may produce far nore net profits than on merchandise on which
the margin is much higher because of the rapid turn-over, large
sales and low carrying and selling charges. A dozen of an item
listed for $2.00 per dozen may frequently be sold at a profit
for s|5l,90 a dozen, (although it rarely happens that a whole-
saler gets but a margin of 570) but the sale of the same item
in one-third dozen lots at .405^ may be hopelessly unprofitable.
Hovfever, competition has sometimes resulted in the sale of
popular mierchandisc on both inadequate margins and uneconom-
ical quantities.
The v/ell m.anaged full-line service v/holesaler can be succ-
essful as has been proven by the ably directed houses in the
drug field. Some have successfully m.et price competition
from, direct buyers and have demonstrated to manufacturers that
they can serve the retail trade for the producer as well as
he himself could do it. On the other hand, some other v/hole-
salers have consistently upheld uneconomical policies. One
practice which decreases the profits of the middlem.an is the
tendency toward too small and too frequent purchases of fast
I
SCHEDULE VIII
DRUG WHOLESALERS IN THE UNITED STATES
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United States" - 1950, vol. 2.
im
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selling, large volurae itei:is. This practice has resulted in a
situation where the wholesaler tended to increase the sales
price of the merchandise to the retailer in order to raake
up for the loss incurred through unsound purchasing and gen-
eral management policies. The retailer, unable to meet chain
store prices through this increased cost, recognized the savings
that could frequently be made through direct purchase of items
that could be sold in the retail stores quickly and in large
voluirie, and proceeded to either foiTa various other types of
wholesale houses or to buy directly from the manufacturer,
-Co-operative s-
Although the co-operative inovenent is a relatively recent
development, its importance is increasing each year. It is
generally conceded that the movement has been due, in large
part, to the efforts made by independents to secure the same
buying pov/ers which the chain stores enjoy. It has usually
been assumed that the size of the order is the one thing in
which the manufacturer is interested, and that an equal dis-
count should be allov/ed on orders of equal sizes.
Logical as this reason seemis to be, there are two fallacies
in this assumption, both of which are a part of the reason
why co-operative buying associations are not as successful as
those who participate in them generally assume that they will
be. First, the neglect to take into consideration "increasing
!
costs", that is, triat a continually increasing volui:ie does
not mean a continually decreasing cost, for costs decrease
only up to a certain point beyond which they either remain
stationary or increase. A mere increase, therefore, in the
size of an order does not always justify a lower price, though
many manufacturers do not realize this principle. It is true
that this principle applies to chain stores just as effectively
as it does to cooperatives, but here a second factor enters
into the picture. The chain is capable of promising and del-
ivering much closer sales co-operation and, too, ij.ore effective
selling in all its stores than can the co-operatives, which
has typically little control over its members and member stores
The mere placing of a large order by a group of stores does
not L.ean that more of the company's product is being sold in
those stores th- n when their small orders v/ere recieved by the
manufacturers separately. It is true that the cost of hand-
ling one large order is usually less than that of many small
ones, but it is not the onl:' concern of the manufacturer, lie
is interested in total costs and in the total volume of his
products sold within a given period, and not only in the size
of a single order. The manufacturer feels justified in giving
the chain store a price advantage, because the latter is like-
ly to secure, store for store, a much greater volur^e than will
a co-operative group of independents.
Though a co-operative buying organization is generally
thought of in connection v/ith.'independents , smaller drug-chains
I*
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have apparently found sorae advantage in this fori., of buying,
not to be obtaine ! in other v/ay. Probably the largest co-op-
erative organization of drug chains is called the Associated
Chain Drug Store, v/hich raaintains a buying office in Wev/ "York
City. In 1927, the membership of this organization represented
thirty coiiapanies having five hundred stores, with sales of
approximately $100,000,000 , In 19^0, the association had 22
members with 1,200 stores.* This organization nov/ ovms the
H.S.Benedict Company, Inc., of Nev/ York, and in addition to
its jobbing functions, produces a number of articles under
its own name which are sold both to member stores and to out-
siders. The association has for its pLirpose, in addition, the
"exchange of experiences, plans, twtthods, etc., and to afford
full interchange of information and oijinions on all subjects".
The co-operative usuall;/ confines its activities to those lines
in which the individual chain's volume is not large enough
to allow it to get quantity discounts itself. Sometimes the
pooled purchasing power will allow the syndicate to take the
output of an entire factory.
The Affiliated Drug Stores is another co-operative drug-
chain organization having about thirty members with five hun-
dred stores. Its members are .smaller organizations, and it may
assumed that they buy a much greater percentage of their total
volui'ie through the co-operative than those belonging to the
Chain Store Age" VIII, Feb, 19, I93I- no. 2.
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Associated Chain Drug Stores*.
The laajority of products purchased co-operatively by the
chains are standard merchandise not subject to such capricious
demands as that of novelty and less standardized goods, while
the situation is somev/hat different in the case of independent
co-operatives. In the latter case, the tendency is for the
co-operative buying office to discover novelties and sundry
items for sale and to urge the independent merchants, v;ho have
little chance to scout for such articles, to handle them. Typ-
ically, this class of merchandise is very profitable but must
be selected with care as to kind and quantity, otherv/ise profits
of many sales are dissipated on one poor buy or on carrying
surplus stock. The co-operative buying office is in a much
better position to make the selections than are the individual
merchants for whom they act.
Aside from this advantage in co-operative buying, the indep-
endent has others, the most iiiiportant of which are;
(I) There is created through co-operatives a more central-
ized control of finances, advertising and inventory,
(S) Selling can be made more effective through coordination-
it affords the retailer an opportunity to get a maximum turn-
over and a rinimum inventory.
(3) It affords the retailer an opportunity to recieve the
benefits of the organization's ...roduct testing and, possibly,
* "Chain Store Age", VII - Feb. 1931.
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manufacturing laboratories.
(4) He can obtain the merchandise at a lov/er "net" purchase
cost
.
The extent of co-operative v/holesaling to independents in
the drug trade, at the close of the year 1927 may be summed
up as follows; there v/ere tv/enty-six co-operative v/holesalers
,
supplying 15,000 independent druggists with $50,000,000 v/orth
of merchandise. In other v/ords, 30% of all the independent
druggists v/ere buying about 12^ of all their drug store mer-
chandise through these wholesalers.
Hov/ever, co-operative buying activities of both independents
and drug chains are not inportant in conparison v/ith the total
voluTde of trade done. I'or the most part, the organization
formed to carry on the work of the s^mdicate is small, consis-
ting of a manager with, perhaps, an assistant or two. The man-
ager acts as the purchasing agent and buys only on specific
instructions froia members. Only when members agree to purchase
certain goods in co-operation by taking, for example, a certain
percentage of the output of a factory, are they bound to
purchase anything through the s:/n.dicate. In other words,
members place their orders much as they v/ould with a jobber
to whom they specify the price, although usually such co-oper-
atives are not operated for profit. A near relative of such
co-operatives is the L.utual .wholesaler who not only operates
on a non-profit basis but who goes even further in giving to
members all profits acquired during the year.

-Mutual ./holesalers-
The "basic difference between co-operatives and the mutual
wholesalers is one of degree rather than one of kind. I'he
latter, in order to keep operating costs at the lov/est possible
point, employs no salesnen, issues no catalogues or other ad-
vertising materials and carries in stock only merchandise
which sells quickly and in large volume. The interest which
a retail druggist member feels in a wholesale house, of which
he IS part ovmer, is depended upon to bring to it the bulk
tk^ ba^ik of his purchases in the items it carries, without
further solicitation or advertisement.
Another factor that helps to reduce costs still further is
tjthe policy of cash sales or rigid and short term credit.
Even the operation of the credit system serves to provide the
organization with the necessary working capital at little or
no cost. For instance, The Philadelphia V/holesale Drug Companj?"
( a mutual house ) requires that a retail druggists, who wish
to make purchases there, first deposit §300 with the company,
on v/hich deposit he recieves no interest, i-ill purchases must
be paid within one week. If thejr are not paid then, a penalty
of 2% is added to the bill- if the druggist again fails to
pay for the following week's purchases, he is automatically
barred from the further credit. The hp300 is a protection
being miore than sufficient to cover a possible indebtedness.
"Full-fledged" mutual houses are usually co-operative in
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tiie sense that the year's earnings, except possibly a snail
reserve, are returned to the raenibers at the end of the year
in proportion to their purchases. This basis of distribution
appears to be most logical since raenbers are usually allowed
to have only one vote or share in the organization and it,
therefore., v/ould be unfair to the large purchaser, who prob-
ably makes it possible for the organization to keep their fig-
ures in black ink, to recieve but a proportionately small
part of the net profit. However, other mutual drug houses
follow the policy of making prices to members as lov; as poss-
ible. That is, they attempt to set prices on merchandise which"
will make receipts just sufficient to cover ^their total costs,
and still leave a siuall reserve. In this way it is generally
believed that any savings made possible by buying from them
become immediately apparent that these savings are equally
distributed in accordance v/ith the volurrie of purchases.
Although such a system of co-operation is very effective
in E.any cases, still the popularity of such organizations is
not so widespread as it could be. Probably the most import-
ant reason for this situation is "poor management". The or-
ganizations try to save monej by employing inefficient men
at lovr salaries. The person who has executive ability and
enough energy to conduct a wholesale drug house successfully,
usalljT" prefers to start, or become an employee, v/ith an or-
ganization in which he can earn not only a salary, but share
in the profits created by his efforts. Such an incentive of
1>
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"profit sharing" by the managenient is usually absent in mutual
houses with the result that the greatest amount of prod-
uctive effort is not exerted by the manageraent
.

-76-
?.etailing; :
Since it is usually too expensive and too troublesorae for
the drug manufacturer to sell ''direct", or for the consumer
to buy "direct", for personal consuiax^tion, the service of the
retailer is really to assemble at convenient points, from
nui-ierous sources, the various kinds of drugs and sundries
which consumers demand. The retailer' enables the consuL.er to
purchase a variety of goods in snail ariount, on short notice,
and v/ith a minimum of trouble. Incidental to this service, the
reta/1 druggist m.ust finance these operations, bear the risks
involved and create a demand for his services.
Important develojpments of the last half centur;/ have had
a marked effect on both the methods and policies of retail
drug stores. One of these developments is the improvement of
transportation and coimiunication. Because of these changes,
it is nov7 unnecessary for the retail druggist to stock heavily
in norm.al times. By merely calling, telegraphing or v/riting
a nearbj'- distributing agency one can start his needed goods
on the v/ay. There is thus miade possible to the retail druggist
a very close correlation between supply and demand.
Rapid progress in drug manufacturing has likewise had mark-
ed effects in the retail field. Kew preparations, new prescrip-
tion and new patented medicines are constantly brought on the
market, either as modifications or duplications of items already
on the market or to meet heretofore unrecognized wants
. With
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the development of rrianufactured phanriaceutical products,
iiiuch of the tii'ie that the druggist formerly/ spent in preparing
prescriptions and providing reraodies is no longer needed
for that purpose, and as a result, he has become raore largely
a distributor of pills and patent nedicines. On the other
hand, riiodern manufacture has provided the drug store v/ith
such side lines as toilet articles, photographic supplies,
stationery and candies of all kinds.
The development and increased use of national advertising
by drug raanufacturers and v/holesalers has so stimulated the
demand for certain products that the retailer is often forced
to carry them against his v/ill, in order to keep the trade
of customers v/ho are induced to call for the items by the
sales efforts of their producers. These advertisers have made
the druggist's position even more difficult by trying to educ-
ate the public against the substitution of other goods for
the advertised product. This, of course, increases the variety
of goods that the druggist must handle and slows up his turn-
over, thus increasing his operating expenses.
Finally, the development of branded goods, as well as
advertised and packaged cormnodities , has also affected ret-
ailing. It has remaved much of the trouble of weighing- and
packaging, has rendered it easier to keep the store neat and
sanitary, has changed the selling problem by Fxaking sale through
narr.e and description tr.ke the place, m.any times, of the unaided
I1
-78-
efforts of the druggist. This develop-:.ent has also reraoved
from the retailer a large amount of the ultimate responsib-
ility* for the quality of the drugs delivered.
In spite of these advantages, the retailer is the most
expensive unit in the distribution of drugs for personal
consutnption, recieving 34% of the consumers dollar as con-
pared Y/itli the 11% acquired by the v/holesaler. Figures of
this kind show nothing of themselves concerning the effective-
ness of the retailer but they do show, hov/ever that v/e , as
well as the manufacturer, pay heavily for the retailers ser-
vice, Furthermore, the range in expenses of drug stores, of
substantially the same character, is so great as to 'warrant
the belief that a large i^ercentage of our drug stores are
operated at an excessive cost.
Since the retailer is the last and probably the most imp-
ortant step in the movement of rierchandise through the dist-
ribution channels, any inefficiency on his part tends to
offset any economies previously made by the mianufacturer and
the wholesaler, Such v/aste in the retail distribution of drug
products reflects itself, therefore, not only in the profits
of the retailer but also in the sales and profits of manufac-
turers, wholesalers and all others directly or indirectly
concerned. It seems only natural, then, that the manufacturer
is v/illing to allov." a premium to the most efficient type of
* For responsibilities of retailers, see page iI2.
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distributor in the forii of discounts. This v/illingness on
the part of the producer fostered the dovelopnent of var-
ious types of retail establishments, the most outstanding
being:
(1) The individually owned drug store
(2) The chain drug store
(3) The mail order house
(4) The department store.
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INDIVIDUALLY O^mKB DRUG STORES
As clearly shown by an analysis of retail trade statistics,
( see schedule IX, page 81) , the unit drug store is today
the prevailing means of retail distribution in the United
States. The reasons for the strength of the unit store in its
competition with chain stores, department stores and mail
order houses may be described as follows;
(1) Convenience to the customer- the fact that the usual
purchase in a drug store amounts to about 50^ is a great in-
dication that drug store purchases are merely casual ones,
purchases that a person is not justified in going far out of
his way to make, even for the sake of saving a fev/ pennies.
This is well illustrated by the "corner drug store".
(2) Complete stocks- prosperous neighborhood and city drug
stores usually have a more complete stock than has the av-
erage department store, nail order house and chain store.
There is a greater tendency for the unit store to carrj^ a
more com^plete line of novelties than do the chains.
(3) Personal service- the personal service of the proprietor
to the public frequently results in his building a strong
personal clientele.
The sane sources however point out various disadvantages
of the unit drug store, the most important ones being;
(I) Management- the individually owned drug store is liable
to be poorly managed, i.lthough this is not necessarily an
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inherent v/eakness, it is a coLTiLion one.
(2) Trade area- the limited area from v/hich the neighbor-
hood druggist can drav/ his business. This condition very often
precludes the possibility of a large business.
(3) Advertising- newspaper advertising cannot be used to the
best advantage, for the cost of effective advertising, in
view of the limited patronage, is often too large in proportion
to sales to warrant the expenditure.
(4) Purchasing agents- purchasing v/eakness is probably the
greatest disadvantage of the unit drug store. Because they buy
in relatively snail quantities, the buyers of such small estab-
SCnSDULE IX
THE DRUG RETAIL TRADE
(1933)
TYPES
Total
Number
of Stores
Total
Net Sales
(000)
No. of
Proprietors
(000)
Total
Payroll
(000)
Independents 53,341 788,568 56,433 91,524
Chains 3,750 267,299 140 32,816
All Others 1,360 10,385 1,176 2,164
TOTALS 58,461 1,066,252 57,749 126,505
Taken from; "Statistical Abstracts of
the United States" 1936 ed.
I
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lishir.ents are not able to keep in close contact v/ith market
prices of drugs, and unlike chain stores, department stores
and mail order houses, are not capable of taking advantage
of any favorable market variation.
Perhaps the most difficult retail function of the indep-
endent druggist is buyin,^^ since his service is to assemble
goods for the dispersion to his personal clientele at the
latter' s convenience r^n<^ lorientary demand. It is generally
agreed that the safesi: ouying polic;/, with respect to indiv-
idual iteris, is one which contemplates the purchase of not
more than one or two months supply of the merchandise needed
at one time. This is not always practical, however. An un-
fortunate tendency in the buying policy of many independent
druggists Is to bu:,'- no ular and readily/ salable merchandise
in too small quantifies, and merchandise that is difficult
and slow to sell in too large quantities. This weakness could
be easily overcome would the independent realize what an
important part that stock-turn plays upon his net profits.
Recently, there has developed a tendency for retail druggists
to recieve a great deal of assistance in selling from manuf-
acturers and jobbers. A part of this is direct, as illustrated
by som.e of the forms of dealer co-operation: window cards,
display materials, circulars of manufacturers giving to the
independent advice on selling, accounting and other retail
problems. Some assistance is indirect, the chief item of which
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is the "national" advertising of drug nanufacturers , In so
far as the manufacturers' efforts are really effective in
linking the independent with the demand created, the latter 's
selling problems are piade easier. The dealer can now exert
less effort in the sale of the advertised goods, since the
demand is created to a large extent by the manufacturer, and
give more tir.e to becoiue active in influencing people to dem-
and HIS services in rendering the advertised goods to them.
But to the extent that all independents, as well as other forms
of retail dealers, equally? recieve the benefits of such ad-
vertising, it simply means that a force of competition is
felt at other points, especially as to selling policies.
This competition is by no means detrimental either to the
consumer or to the m-anufacturer . The consumer benefits through
lov/er prices, better service and cleaner stores. The manufac-
turer in turn benefits larger sales. Because of this compet-
ition between independents, and independents v/ith chains,
the retailer has resorted to use more effective layouts and
more suggestive displays. They have realized that the more
merchandise there is to be seen in a retail drug store, the
greater the opportunities for the quick and profitable sale
of that merchandise. The usual drug store carries in stock
from 10,000 to 15,000 different items of merchandise, and
since people who coi::e into a drug store therefore cannot be
acquainted with all the different kinds of merchandise it has
i
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for sale, druggists use displays as an effective means of
bringing the merchandise to the attention of customers and
prospective customers. Such a medium is evidently beneficial
both to the producer of the goods and the purchaser of the
goods.
There are five inajor types of individually ovmed drug
stores in the United States today. A brief description of
each type will suffice.
(1) Center Drug Stores in Cities;
The average volui.ie of sales done by some stores is about
5^85,000 a year upward. Such a large volur:.e permits the store
to obtain a turn-over of about once a month, thus decreasing
the total cost of operation. However, this advantage is offset
by the exorbitant rent charges and large personnel payroll.
The nuTfiber of drug stores of this t;^nDe in the united States
is relatively small, probably due to the fact that suitable
locations, locations which make the store easily accessible
to a large nuraber of people, are liiidted in number.
(2) Neighborhood i)ru.g Stores in Cities;
The usual volume of sales done by these stores is about
$20,000 a year. This type of a store has miany advantages
the principle ones 'being- a low initial investment (about f6,000)
the proprietor is in a position where he can establish a good
personal clientele, low labor cost. These advantages are often
offset, partly at least, hj the manotony of long hours and
1I
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tedious v/ork.
This type of drug store is the laost popular in the United.
States today, as well as the most nuinerous. This is probably
due to the fact that it is, of its very nature, largely a
convenience store. There is a great demand among the consuming
public for this service, v/ith the result that stores of this
type are established at all points where it is believed that
it v/ill be accessible to a relatively large nuiaber of people.
(3) Small City Drug Stores;
Like the neighborhood store, these drug stores in snail
cities usually have a sales volum.e of about $20,000 a year.
The proprietor of such an establishment has the advantage of
a low rent charge. The rate of turn-over ranges usually from
tv/o to three times a year. Such a low rate is probably due to
the fact that such stores often carry a very diversified line
of novelties together with such items as seeds, fertilizers,
lamps and new fads. Ijlanj of these side lines are very seasonal
and therefore such stock that is carried over from season to
season decreases his rate of turn-over.
A very large proportion of the drug stores in the united
States are found in these small cities. In fact, 76% of all
the drug stores are situated in cities of less than 10,000
population. Such a high percentage is only natural since
almost half of the total population of the United States still
live on farms or in cities of under 2,500 population.
•I
I
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(4) Suburban Drug Stores;
These stores cater to the more wealthy people in suburban
and residential corjiiunities . It is easy to see that such
stores must base their sales appeal on quick delivery, exten-
sive credit and a very efficient telephone order service.
Their stock must be varied and exacting, which means that
the stock turn-over is very slow.
Although the total cost of operating such an establishment
usually runs into high figures, the mark-up on goods sold is
higher. Since these stores are usually located at considerable
distances fron city districts, they have little or no compet-
ition. The volume of business amounts to a figure consider-
ably above that of most drug stores, even reaching f100, 000
a year.
(5) Professional Pharmacies;
Such drug establishments recieve their income by perform-
ing professional services, filling prescriptions and selling
sick room supplies. This tjrpe of drug store is relatively un-
important in the United States today. In fact, they number
but about 2,000.
These stores are usually located close to physicians' center,
acquiring their business mostly by filling out doctors' pres-
criptions. It is evident, therefore, that the ovmers of such
establi sliments try to obtain the interest and goodwill of
physicians.
I
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A relatively recent dcvelox^raent in the drug retail trade
is the installation of fountains to attract customers. Hist-
orically, the fountain grew directly out of the prescription
department. Uot so lo.any years ago, carbonated v/ater was dis-
pensed in drug stores as a remedy for indigestion and other
ailments. After a few years, the beverage possibilities of
carbonated water v;as discovered and it began to be customary
to carry a few flavors in this connection. Thus the fountain
and luncheonette of today came into existence by a long series
of steps, and even at present, the change of style in foun-
tain fixtures is so sudden that such fixtures suffer great
risk of becoming obsolete long before they have served their
full period of usefulness.
Such a risk hov/ever pays good dividends. It has been shovm*
that 26.1 °/o of every sales dollar of a drug store comes from
the fountain, the department that yields the highest sales (see
Schedule X, page 88). It has been tabulated that out of every
II80 persons entering drug stores, 590, or 50>t», go directly
to the fountain. That the fountain is a great attraction is
proven by the fact that 2158 persons out of the 590 mentioned
above go to other departments after they leave the fountain.
There are about 50,000 retail stores in the United States
today with individually ov/ned stores making up about 97% of ,
this total. In I9;55, these stores, combined, sold over a bil-
lion dollars worth of merchandise. Although the independent
* U.S. Domestic Commerce Series- 1932, Doc. 57-66.
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druggists sold 300yo more raerchandise than did the chains,
sales per independent store averaged but ?|525,000 while those
of chain stores averaged nearly cj;85,000 per store.
SCHEDULE X
DRUG STORE SALES DOLL.'IR
(April I93I- April 1932)
Taken from; "Costs, Sales, and
Profits in the Retail Drug Store"
Don, Coiran, Series- Doc. 90,
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SCHEDULE XI
OFEIL^TING EXI^ENSES IN RETAIL DRUG STORES
-I9I9-
(Net Sales- 100 Per cent)
Items
Net Sales
Cost of Iv.erchandise sold
Gross Margin
Total Salaries and ;/ages
Advertising
Boxes and rapping
Delivery
Office Supplies and Postage
Rent
heat, Light and Pov/er
Taxes
Insurance
Repairs on Store Equipment
Depreciation on Store Equipment
Total Interest
Losses from Bad Debts
Miscellaneous Expense
Total Pxpense
Profit
Stock-turn {Times a Year)
C omiflon
P'igure
in
I9I9
100.0 %
66.0
34.0
15.6
0.7
0.6
O.I
0.3
g.8
0.8
0.4
0.4
0.2
0.6
3.1
0.3
1.5
27.6
6.3
2.3
Taken Prom;
The ^'National Uistrihution oonf erence''
vol. IV, p. 29.
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CHAIN DRUG STORES
The idea of operating a number of retail units by a cen-
tralized management is not nev/, even though its introduction
into this country upon a large scale is so recent that agit-
ation against its form of retail organization has not, as
yet, entirely subsided. It is probably correct to say that
those who began this chain movement had no idea that they v/ere
creating systems which would have the far-reaching economic
consequences they have had.
The chain store era in the United States began just prev-
ious to 1900, even though its great development has coa.e since
that time. One reason for its rise, as previously mentioned,
was the price-cutting war that developed among the indep-
endent retailers of the late nineties; while, another reason
is the result of a peculiar situation arising froni the very
nature of a drug store business. The average sale in a retail
drug store ranges from twenty cents to about eighty cents,
with the most usual figure running at about fifty cents. The
fact that the usual purchase amounts to but fifty cents is
a mathematical indication that purchases in drug stores are
mostly casual ones, m.ade at the most convenient place. This
means that the area from v;hich a drug store can draw its bus-
iness is limited by the comparative accessibility of other
stores offering similar or identical merchandise ,
As a result of this, a druggist reaches the limit of prof-
itable expansion of his store when additional expenditure of
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capital and labor does not return, proportionately, additional
sales due to the limitation of his area of trade, A pros-
perous druggist v/ould believe, for instance, that the prin-
ciples and methods he has used to make his store successful
can be applied to another store v/ith equal success, a second
store is established or purchased, and if this one, in turn,
proves to be a profitable enterprise, he proceeds to open a
third— and so on. Soon he finds that he is in a position to
establish favorable purchasing relations directly v/ith the
manufacturer of his fastest selling iteLis.
There is no doubt but that the rapid growth of chains
has been made possible through the purchasing advantages
v/hich they possess, which advantages are largely ascribed to
the fact that tliey buy in larger volume than do their indep-
endent competit iors . On the other hand, it might be thought
that, in purchasing such large quantities of merchandise,
these drug chains would run a great danger of loss through
fluctuating market values, ^.s a matter of fact, this possib-
ility has probably been reduced by the chains more than by
any other agent engaged in marketing activities. In the
first place, retail prices usually fluctuate less rapidly
than wholesale prices, and since the chains buy only for short
periods in advance, the possibility of disposing of merchan-
dise before a change in price is greater than it might other-
wise be. Yet, in the drug trade, the very presence of the
chain stores has made retail prices exceedingly sensitive to
II
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changes in wholesale prices, especially v/hen the trend is
downward. The policy of sorae drug chains is to reduce their
retail prices as soon as v/holesale prices are reduced rather
than to v/ait until the stock on hand is exhausted, whereas
in a rising narket, prices are not advanced on competitive
goods until it is necessary to purchase additional stock,
for drug chains, like other retailers, are generally reluc-
tant to raise prices.
In the second place, the drug chains have succeeded most
remarkably in getting the manufacturer to bear the market
risks caused by fluctuating prices. The purchasing contract
usually calls for the manufacturer to guarantee to the chain
that if, after an order has been placed, prices fall, the
manufacturer v/ill refund the difference between the original
purchase price and the new price. In some instances, this
refund is made on merchandise still in the chains' ware-
houses, although sometimes it applies to undelivered goods
only. On the other hand, if prices rise after the chain has
placed an order, the manufacturer agrees to bear the loss**".
Some may wonder why luanufacturers should be willing to
take such chances and agree to such contracts. There are tv/o
reasons; (I) they are so anxious to secure the chain's bus-
iness that this concession offered by one manufacturer is
necessarily offered by competitors who hope to retain or
The manufacturer may not bear the risk, of course, if he
has hedged, or has purchased his raw material at the
time that the contract was made.

secure a part of the business, and (2) such a guarantee
induces the chain to order in advance, thus enabling the
raanufacturer to plan his production iiiore satisfactorily.
Although the chain stores buy a vast majority of their
merchandise directly from the producer, a considerable
amount of business is given to wholesalers and jobbers (c.f.
Schedule VIII). They are used by chain drug companies under
such conditions as the following;
1) In emergencies,
2) In buying items, the sales volui'ie of which is small,
"6) In case a "full line" bu^'- is necessary from the manuf-
acturer and it is not advisable from the standpoint of the
chain, and
4) ./here merchandise can be obtained onlj from the wholesale
The drug chains, today, usually miake arrangements with
local jobbers in the cities in which they operate to supply
their units whenever they order. Thus, when the chain unit
has exausted its supply of an item and delay in shipping
from the company's warehouse is unavoidable, the stores are
usually authorized to order fron a specified jobber. In some
cases, the sales volurae of certain articles is so small that
the chain can iiiake no savings from direct buying. Sometimes
m-anufacturer s specify that the complete line (say of shaving
materials) must be ordered, whenever any item in the line is
wanted, if additional discounts are to be given. ,Very often
one item in the line will sell faster than the rest, and.
i!
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SCIIEDULE XII
SOURCES OF SUPPLY FOR SPECIFIED PRODUCTS PURCHASED
BY CEAIII DRUG. COIfl'AKEES *
COmODITY NO OF
xv-UjX^w.n.x o
all chains
% purch/lsed from
Iv'lFG'ERS Vra'LSERS
Photographic Supplies 15 83.4 ie.3
Stationery 26 69.8 30.2
Candy and confectionery 64 68.0 32.0
Rubber goods 22 67.6 32.4
Hospital Supplies 19 63.0 37.0
Toilet articles 84 56.9 42.5
Fountain and lunch 69 55.0 44.1
Drugs 134 40.0 58.4
Sundries 62 33.2 66.2
Proprietaries 68 33.5 65.7
Tobacco Products 86 18.6 80.6
72d Congress, 1st session, Senate Document 30,
p. 54, Table XXIV
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ratlier than order the whole line thus creating a surplus
of certain stock, the chain v/ill order the one item froir. the
v/holesaler. Lately however, there has been a tendency for
producers to break down these lines and sell individual items
to chains, regardless of the size of the order.
Drug chains, it ^was reported in I9£4, purchased less than
one-fifth of their merchandise from the jobber, while the
average independent store bought approximately 60';o of its
needs from that source*. Of 132 drug chains reporting to the
Federal Trade Commission Survey**, 121, or 91.7%, purchased
from manufacturers; 7, or from growers; 15, or II. 4 %,
from brokers; 132, or 100%, from, wholesalers; 10, or 7.6 %,
from other sources. Again, drug chains reported that 78,3 %
of their purchases came from manufacturers and 20.4 fo from
wholesalers. The remaining 1.2 fo came from brokers, growers
and other sources.
A practice which has become quite common ai'iong chain drug
companies is engaging in the manufacture of their fastest
selling items. Although this practice is popular, it has not
developed to a very great extent as measured by the proportion
of total store sales to their ov/n manufactured products. In
1933, there were 31 of 144 drug chains in the manufacturing
business, but only three of these produced more than 25 % of
the goods sold in their stores, while the proportion of all
* Harvard Business Review III, no. I, (Oct. 1924) G9ff.
* 72nd Congress, 1st Sess., Senate Doc. 30.
II
1
1
i
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drug chain sales so manufactured was only 13.5%, In 1930,
the total sales of goods manufactured by chains v/ere $28,588,000
distributed as follows:
Chains having;
2 to 5 stores - manufactured ,^Jo
6 to 50 stores- manufactured 3.9%
51 to 500 stores- manufactured 58.0%
Over 500 stores - manufactured 37.7%
Of the total sales made by these manufacturing chains, but
86.4% were made in their ovm stores while 13.6% were made to
v7holesalers
,
I\/lany of the drug chains have entered into the manufacturing
field, because for the most part, the organization of such
a subsidiary (or departm.ent) is exceedingly simple, since
the manufacturing processes themselves are very elementary.
Its organization may consist of a manager or foreman at the
head of laboratory activities, who is usuall^r a chemist or
laboratory specialist. To aid him is an assistant and the
factory employees. This is all the organization needed since
the purchasing department and the factors?" output is taken by
the company's stores. Financing and accounting are also hand-
led by the proper chain departments and headquarters.
Aside from this advantage, ther.e are many reasons why man-
agement officials of drug chains have found it desirable to
manufacture
;
(I) Profits-- Manufacturing gives the chain a chance to
secure additional profits without a corresponding increase in
1I
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the risks of business. The percentage or ^orofits to be obtained
from the manufacture of certain toilet and proprietary prod-
ucts is enormous (for example, the percentage gross profits
to sales ratio obtained on Bay rum is 62,2 ^, on toilet water
is 63,7 )jy on Glycerine is 64 fo*X
Another factor which makes the chain's own manufactured
goods profitable to handled is the possibility that exists
for controlling resale prices. Direct competition is not en-
countered in the sale of this ra.erchandise and a price may be
established and maintained which v;ill yeild a satisfactory
profit
,
(2) Simiplicity of manufacturing operations-- The simple
process involved in manufacturing som.e of the most profitable
merchandise is one very important reason v/hy the chain has
been able to engage in this activity. Some of the operations
which are classed as manufacturing are little more than pack-
aging and labeling operations on which large profits can often
be made, as in the case of bottling bulk alcohol.
(3) An assured market-- Because the chain is in control of
its outlets, it is sure of being able to push a larege quantity?-
of its own products into the trade trough; in relation to
total sales, though, the amount is usually small.
(4) Inabilitj^ to secure a satisfactory su_,jply of a commodity-
sometimes the chain manufactures a product for v^rhich it has
* Sarcples picked at random from Catalog.
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been unable to secure a satisfactory source, probably due to
an inability to get the item at a desired price and in the
desired quantity.
( 5 ) To improve quality— Another reason advanced by chains
for engaging in manufacturing is the necessity of improvement
and the control of the products which they sell. Chain chemists
assert that chemical tests often show that the goods made by
their com.pany are superior in quality to those manufactured
by others which sell at a higher price,
(6) Prestige— Chains believe that customers are likely to
be favorably impressed with the size and importance of a con-
cern having its ovm. branded products.
Although most drug chains have found it desirable to control
some of the products which they sell, the ratio of the sales
of such products to total sales is rather small. Even the
Liggett Company, the most successful manufacturing chain,
estimates that the volume of its ovm goods is not m.ore than
19-20 fo of the total sales.
It is impossible to predict with accuracy how far the drug
chains will attempt to go in their efforts to produce the com-
modities which they sell, but it is certain that they have
not reached the limit of their expansion in this direction.
The Chicago purchasing agent for the Owl Drug Company franlcly
admits that his companjT- intends to produce more and more items
as long as profits v/arrant. He states that manufacturers who
aid in the grovrth of drug chains are likely to be creating
II
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additional competition for themselves. Expansion along this
line is a natural development, according to this purchasing
agent, because a company controlling a large number of out-
lets is sure to seek control over products being sold in them
whenever it is their financial interest to do so.
It is much easier for the chain to engage in manufacturing
activities than for the producer to engage in retail activ-
ities because; (a) the problein of manufacturing is simple
compared v/ith that of retailing, (b) the chains have the most
desirable locations, (c) it takes a large araount of capital
to develop a chain of retail stores in a v/ide area and the
manufacturer setting out to develop his outlets will be hand-
icapped, whereas capital requirements for the manufacturer of
drug store products are small, (d) a producer who attempts
to enter the retail market himself would stir up much oppos-
ition and "would likely lose a good part of his present market.
On the other hand, there are certain disadvantages which
confront the chains when they contemplate producing their ovm
goods; I,- these goods m.ust be displaced to be sold, j^'et a
window of "ovm goods" merchandise does not attract as many
customers into the store as a display of nationally knovm
brands, 2,- their o\m brands require much more time and sales
effort on the part of clerks because they are not so well
knovm, ">,- these often prove embarrasing to the chain v/hen
an agreem.ent v/ith manufacturers of competing products is being
considered, and sometimes stand in the v/ay of complete coop-
eration.
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It is doubtful whetlier the drug chains will ever be able
to manufacture a large percentage of the products which they
sell because, first, the demand created by manufacturers for
their products cannot be successfully resisted in the stores,
and, in the second place, a great variety of merchandise, of
the novelty and sundry type, must be constantly secured and
no one company is likelj'" to find it possible to create these
new products.
From the purchasing and production operations of the drug
chains, let us direct our attention to the selling policies
of such organizations. The main objective of the company is
to get a customer in the store, and to attain this end, use
price-cutting as their greatest weapon. However, such price
reductions are confined to nationally advertised brands and
trade-marked goods, upon which a retail selling price has
been set by the manufacturer. Periodically, one-cent sales
are made on these items, whose standard prices are knovm
to the public, which are very cleverly executed. For example,
Lambert's Cough Syrup ordinarily sells at all drug stores
for 39$3f per bottle, al;J?"hough the price on the bottle is marked
50^^. While a one-cent sale is in progress, the price will be
reduced to tv/o bottles for fifty-one cents, or one bottle
for fifty cents- thereby giving the public a reduction of
but thirteen cents on a bottle, (most probably a higher figure
than the gross "cost to the chain) while most people really
believe that they pay but one cent for the extra bottle.
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Naturally, this will attract the public's attention, and,
although the store makes little or no profit on this itei.:,
it will attempt to use their attractive displays as a laeans
of inducing purchases on other commodities, the sale of v;hich
bears a profit.
Drug store statistics* show that chains in the retail drug
business have increased 120% from I9I9 to 1928, In the lat-
ter year, ten percent of the total nuiiber of chains were drug
chains, while 3.2 % of all chain stores v/ere drug chain stores.
In this same year, there v/ere 179 drug chains with a total
of 1,994 stores, operating in forty-five states, the largest
number being in New York, Ohio, Illinois, California and
Pennsylvania, respectively. Of a total number of 118 chains,
52.6 % had sales of from :i^IOO,000 to ^|249,999 annually, while
21.6 % had sales of from ;;;;50,000 to |I00,000 per year-- the
aggregate sales were $121,677,475*, an average of :ipI06,828
per store.
In 1955, the net sales of the United Drug Conpany alone
amounted to $82,759,760, while in 1956 reached a peak figure
of $88,464,982. If one were to add the net sales fror 1956 of
the Sterling, Inc., to those of the United Drug, he would
get a figure almost equal to the aggregate sales of all chains
made in 1928. These two co..panies alone sold, in 1956,
$119,715,371 worth of merchandise, thus showing that drug
* Eastern Drug Iiarket , 1928.
A letter from "The Chairman of the Fed. Trade Comm." 1928
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chains are by no /ioans receding in relative iiiportance.
There has, since the late twenties, developed a "buy- at-
home" movement which is likely to have an adverse effect
upon chain drug stores, particularly the national chains.
The basis of these emotional appeals is to "keep the money
circulating in our ov/n tovm, and don't send it away to make
some big city millionaire richer". Fortunately for the chain,
few people are sufficiently interested in the v/elfare of the
local business man to be v/illing to pay them a bonus in the
form of higher prices for the merchandise they sell. Thus the
chain drug store, basing its sales appeal largely upon price,
has been able to get around this local prejudice to a remiark-
able degree, so much so, that even the proprietors of indiv-
idual drug stores, bitter in their complaints "chain stores",
are often found to be regular patrons of chain grocers or
chain hardv/are stores.
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Exports and Imports:
The basic reason why we iiiust become foreign traders in drug
comiodities resides in the irresistible action of the econ-
omic law of supply and demand. Prior to 1820, before the advent
of the American drug manufacturing industry, we find that crude
drugs were imported in relatively small quantities, v/hile ex-
ports of prepared pharraaceuticals were practically nil. But
since 1900, v;e have reached a stage where our productive cap-
acity is such that we normally'' have a constant surplus beyond
our needs. The output of Aiaerican drug manufacturers is nov/
greater than that of anjr other country, which degree of devel-
opment we have seen to be a direct result of the stimulation
of European demands upon us during the Vvar.
Although it can be said that within the confines of cont-
inental United States are produced all of the absolutely essen-
tial articles required, as food, clothing and shelter, for the
population, such self-sufficiency is not present in the case
of drugs. ,je have always imported more crude botaiicals than
we have exported, although not always in the sanie proportion.
While in I9?i2, for example, we imported but 25% more than we
exported, in 1934 the proportion became almost six to one.
On the other hand, since the United StEites has become the
leading drug manufacturing country in the world, we find that
it exports medicinal preparations, perfumes and cosmetics in
tremendous quantities, far in excess of the imports of such
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SCIiEDULE XIII
EXPORTS AM) I^.xP0RT3 OF DRUGS
- "UiilTED STATES -
(by years)
DivTE EjQ^ORTS IL'IPORTS
Year
; edicine
T* O r"\ O
J. JJ O •
(000)
Crude
(000)
Perfume i
tJ o o •
(000)
'Medicine
(000)
Crude
JJJ. Uf^O
(000)
' Perfumes
A "t"coo*
(000)
191
2
7,608 1,280 1,642 1,810
I9I4 6,521 1,514 735 2,350
I9I6 8,294 3,526 393 5,371
I9I8 10,824 3 , 903 1 , 336 3,180
1920 21,215 8, 740 900 6,967
±922 14,196 3,214 15,223 4,762 4,880 8,684
1924- 17,441 3,543 15,985 4,777 7,902 6,596
1926 19,677 3,578 17,069 5,891 9,221 6,602
1927 20,552 3,273 17,170 5 , 423 9,034 8,197
1928 20,103 3 , 587 15,721 5,179 10,858 7,121
1929 21,282 3,690 16,059 6,422 10,581 6,988
1930 17,610 2,576 13, 972 4,948 7,678 4,785
I93I 15,036 2,413 11,282 3,792 5,925 3,064
1932 9,966 1 , 183 6,422 2,530 5,005 2,038
1933 9,816 1,267 5 , 436 3,568 5,045 2,205
1934 10 , 945 1,650 6,180 4 , 237 6,547 3,238
* Data unavailable. '^'^^^^ ^'^^^^ "Statistical Abstracts
of the U.S." I9I2 to 1936
Dept. of Coimri,
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items (see schedule XIII), In I9I5, manufactured drugs, tog-
ether with chemicals, occupied sixth place in the volix'i.e of
the export trade of the United States- steel and iron acquiring
the highest figure.
That crude botanicals should be largely imported and that
manufactured drug products should be largely exported is a
natural result of our peculiar division of labor in the drug
trade. High labor cost coupled with unfavorable climatic con-
ditions does not permit profitable cultivation of drugs in
the United States. Relative scarcity and relativel:/ high cost
of domestic drug products necessitates the importation of
crude drugs. On the other hand, with highly developed machines
and great men of science at our disposal, we have foujid it
profitable to manufacture these mecicinals in larger quantities
than the American public could consuiae, thus conmianding an
export trade in such manufactured goods.
iiXPORT SALES ORGANIZiVlTOilS
;
There are two miethods of marketing manufactured drug prod-
ucts in foreign countries. The first is through export comm-
ission houses and other middlemen. The second is by the direct
sale of the product from the manufacturer to the foreign cus-
tomer. These customers m.ay be wholesale importing and distrib-
uting houses handling one or more lines of merchandise, whole-
sale or retail drug establishments, or the ultimate consumer.
Instead of using the sales organization of the export house.
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tlie direct exporter devises and controls his own methods of
reaching the buyers of his products, thus assuring a luarket.
A recent practice that has developed ar:iong the large in-
dustrial drug corporations is to establish separate sales
corporations in foreign countries to conduct their export
business. Such subsidiaries are established to reduce export
taxes. It is often the policy of foreign countries to tax
firiris doing business in their territories on their total cap-
italization or profits. However, if a subsidiary is established
as a foreign corporation in the particular country where it
is doing business, it v/ill be able to sue in the courts of
that country to protect its rights. Unless it is so organized
it is liively to be denied that right. For tax purposes, it V'/ill
be necessary to disclose the financial statements of only
the subsidiary sales corporation, instead of both the subsidiary
and the parent firm.
Another plan for developing export business, adopted by a
number of snaller drug companies, is to appoint an export firm
to handle its sales. In most cases the latter assmaes the role
of an independent contractor rather than, in the legal sense,
an agent. For this reason, the manufacturer is not affected
by the taxes imposed upon corporations doing business in that
particular country. Protection of the courts is obtained through
the export firm. The corporation usually sends one of their
men to v/ork for the contractor to insure the proper sales of
the merchandise.
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Le^islation Governing the Drug Trade ;
STATE Am LOCAL LiVv/S-
For the protection of the life and health of the consuming
public, each state now has laws providing for a State Board
of Pharmacy, consisting usually of five or six members, in
most cases appointed by the Governor of the state. In many
states no wages are paid these men, while in others, members
recieve from five to fifteen dollars per day while actively
engaged in the work of the Board. All members must be regis-
tered pharmacists, and some states even require a five or ten
year period of active practice x^receding the appointment. In
many cases, teachers or instructors of pharmaceutical schools
are not eligible for appointment or membership.
The duties of the State Board vary in certain states, but
generally speaking, they must make such by-laws and regulations
as are necessary:
1) to regulate the practice of pharmocology
2) To regulate the sale of drugs, chemicals, medicines and
poisons
3) To regulate the employment of apprentices and employees
in pharmacies
4j To regulate the v/orking hours and sleeping apartments of
employees in pharmacies
5) To regulate and control the character and standard of drugs
and medicinals compounded and dispensed in the state, to
employ inspectors and chemists, to secure samples and to
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prevent the sale of such druir^s, chemicals, medicinals and
poisons as do not conform to the formulae, standards and tests
of the ir'harmacopoeia and Formulary.
6) To regulate the retailing of poisons and adopt schedules
7j To issue temporary permits limited to definite areas
8) To investigate alleged violations of the provisions of
it, this article, to conduct hearings in respect thereto when
it appears to be necessary, and to bring to bring the same to
to the notice of the attorne^^-general.
*
To enumerate all the state and local laws v/ould be prac-
tically impossible. Suffice it to say that all men engaged in
the making and distribution of drugs and drug preparations must
obtain a licence from the state board, subject to revocation.
Such a permit may be revoked for any of the following reasons;
I) Failure to pay the required fee; 2) Upon proof that the
dealer is so addicted to the use stimulants and narcotics that
it may render him unsafe to handle or sell drugs and poisons;
3) Upon proof that the dealer is not of good moral character;
4) If the person is not actively engaged in the practice of
pharmacy; 5) Fraud in the representation of his skill or ab-
ility; 6) Use of untriithful or improbable statements in his
advertisements; 7) Distribution of intoxicating liquors or
drugs for any other than lav/ful purposes; 8) Willful or repeat-
ed violations of this title, the title of "Public Health" or
New York State Laws- 1927, c, 85

the rules of the State Department of Health; 9) Continued
practice while knowingly having an infectious or contagious
disease; (10) Unlawful sale of cocaine or too the conviction
of an offense involving turpitude.
During the past few years, more and more states have passed
a law requiring all pharmacists to have in their drug store
a copy of the latest revision of the U, S. Pharmacopoeia and
the national Formulary. For instance, in Iowa, the statute reads
" There shall be kept in every place in which drugs or med-
icines are compounded a copy of the latest edition or revision
of the U. S, Pharmacopoeia and National Formulary, which hooks
shall he subject at all times to the inspection of the phar-
macy examiners",*
Retail Druggists
Among the various laws of the different states, the follow-
ing may be said to be the essence of all government regulations
with regard to retail druggists: I) At least one registered
pharmacist must be in the retail store at all times; 2) If the
store is owned by a corporation, at least one of the stocldiolders
must be a registered pharmacist, (Prior to 1928, Pennsylvania
had a law requiring all stockholders to be registered pharm-
acists- this was declared unconstitutional in 1926).** 3) In
nearly all states, retailers nust have a copy of the latest
revision of the Pharmacopoeia; 4) All prescriptions that get
* Iowa Code, 1904, # 3150
* Liggett Co. V, Baldridge, 278 U.S. 49 S.Ct, 57, 73 L. 204

into the hands of the druggist must be filed and reserved;
4) Such drugs as cocaine and its allies cannot be sold except
on prescriptions, which prescriptions must be kept on file,
usually for a period of five years, and that no such prescrip-
tions may be refilled, nor any copy of it given to anyone ex-
cept v/hen needed for court purposes; 5) Labels should be placed
on all bottles, boxes or mediuras of packaging v/herain are con-
tained any drugs or preparations. On the labels should be
written the name of the medicine; 6) No druggist shall give
medicinal advise to a customer unless first notifying the lat-
ter that he is not acting as a doctor in the case but merely
in an advisory capacitj^-; 7) The registered pharmacist shall
be responsible for the mistakes of any/all of his clerks.
If the customer asks for a patent or proprietary medicine,
and the druggist delivers the medicine called for, in the orig-
inal package, accompanied by the directions of the manufacturer
for its use, the druggist is not liable for any injury that
may result from its use. The fact that he is a vendor of the
drug does not bind him to analyze the contents of the package.
If on the other hand the druggist have knowledge of the in-
gredients and know them not to be as represented, or any other
danger was involved in the sale of the patent medicine, his
failure to protect the consumer might constitute negligence.
However, the fact that the retailer is not responsible does
not relieve the manufacturer from responsibility.

Manufacturers and Wholesalers:
By lav/, the person who compounds the drug is in a position
of great responaibility toward those who use it. This refers
not only to the retailer but, even to a grater degree, also to
the wholesaler and manufacturing druggist. The latter is liab-
le to a purchaser from a retail druggist for the injurious
consequences of a mistake in the preparation, even though the
article may have passed through a number of intermediate hands.
The very nature of the business makes it a reasonable rule that
the ultimate consumer may bring action against the manufacturer,
bottler or packer of products sold by a retailer in the orig-
inal or sealed package or bottle for the. injuries arising from
the use of such products.
Summarizing the various national and state laws concerning
the liabilitjr of both the wholesaler and manufacturer in the
sale of his products, we would have the following list:
I) Liability of manufacturer to ULTIIvIA.TE consumer, (a) on
theory of tort, (b) on theory of implied warranty, (c) for
injury caused by the use of the patent medicine, (d) on expl-
osion of chemical disinfectants,*
PRICE FIXING AI^D RESTR/aM" OF TRADE:
Has the manufacturer, producer or wholesaler a right to
control the resale prices of his products? Today, the answer
to this question depends largely upon the methods employed to
achieve this end. The following conditions may be stated:
* m, Rav/leigh Co, v. Schoultz (CCA. 1932), 56{2d), 148
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1) Where a "bona fide" relationship of agency exists, resale
prices may be controlled, through agreeraents v/ith, or inst-
ructions to, agents.* But the agency must be one in fact and
not in name only. ,.here title to the goods has passed to the
jobber or dealer, he will not be conidered the agent of the
manufacturer under an agreement to maintain resale prices,**
2) Resale prices can be controlled through announcing a price
policy and refusing to sell to price cutters, where no agree-
ment to maintain prices has been entered into and where the
methods used to enforce price control do not amount to an
implied contract.*** V/here, hov;ever, the manufacturer attempts
to control resale prices by entering into an agreement with
all or a controlling nuraber of dealers in a comraunity , such
agreements have been hald invalid as unlavTful restraints of
trade. The fact that goods are manufactured by special processes
or by secret formulae, or are patented, copyrighted, or trade-
marked, is irmiaterial in considering the validity of a contract
imposing conditions as to resale prices after the right of sale
has once been exercised by the manufacturer ,"*"*** neither can
he create a contract relationship betv/een himself and a third
person into v;hose hands the goods may come by attaching a prin-
ted notice to the goods or on a label, imposing conditions in
attempting to control the resale price in the hands of any fut-
* Cole Liotor Car Co. v. Hurst (CCA. I9I5) 2S8 F, 280
** U.S. V. Kellogg Corn Flake Co. (D.C.I9I5) 222 F. 725
*** U.S. V. Colgate, (I9I9)
**** Dr. I.iiles Med. Co. v. John D. Parks & Sons, 220 U.S. 373

-J.J. o-
ure purchaser of the goods.
The foregoing may seem like an academic discussion at pre-
sent when ruthless competition and its attendant price-cutting
is no longer considered an unmixed social blessing. Tha anti-
trust laws, both federal and state, were in a state of virtual
suspension a fev/ years ago, partly as a result of the neglect
of the codes of the recent N.R.A. to take these into consid-
eration. It wasn't until 1957 that interest in the subject
by the American government was revived.
However, a contract in restraint of trade can be made and
enforced if its terms are reasonable and if it seeks to ac-
complish a lavt/ful end. Contracts are generally upheld as valid
v/hen they are agreements, " I) By the seller of property or
business to compete with a buyer in such a way as to derogate
from the value of the property or business sold; 2} By a
retiring partner not to compete with the firm; 3) By a partner
pending the partnership not to do anything to interfere, by
competition or otherwise, with the business of the firm.; 4) By
the buyer of property not to use the same in competition v/ith
the business retained hj j-he seller; 5) By an assistant, ser-
vant, or agent not to compete Vizith his master or employer
after the exploitation of the affairs and the expiration of
his time of service. Before such agreements are upheld, hov/-
ever, the court must find that the restraints attempted there-
by are reasonably necessary (1,2 and 3) to the enjoyment by
the buyer of the propertj?-, goodwill or interest in the part-
I
nership; or 5), To the possible prevention of injury to the
business of the seller from the use by the buyer of the thing
sold; or 6 ) To protection from the danger of loss to the emplo
yer's business caused by the unjust use on the part of the
employee of the confidential knowledge acquired in such a bus-
iness." *
Hj-VRRISON iU^CI -narcotic ACT:
h
Tis is " an act to provide for registration of, with Coll-
ectors of internal revenue, and to impose a special tax upon
all persons, who produce, import, manufacture, compound, deal
in, dispense, sell, distribute or give av/ay Opiuni or Coca
Leaves, their salts, derivatives, or preparations, and for
other x)urposes." **
Although this Act is in form a revenue act, the enforcement
of its provisions has proven to be productive of a number of
social and moral benefits, sorae of which have been; I) The
restriction of the distribution of narcotics to medicinal uses
2} the careful and proper supervision of the traffic in such
drugs, '5) a minimizing of tbe spraed of drug addiction, and
4) the accomplishiient of certain moral benefits. This act,
by the v/ay, was declared constitutional in the year I9I8. ***
* Taft,C.J. in U.S. v. Addyston Pipe and Steel Co. (1898)-
85 271, 79; C.C.A. 141, 46- L.R.A. 122.
** December 17, I9I4.
*** Hughes V. U.S., C.C.A. I9I8- 255 F. 543.
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FEDERAL FOOD AInID DRUG ACT:*
Its scope is to prevent the manufacture, sale or transport-
ation of misbranded, adulterated or deleterious foods, drugs,
etc. It applies to food and drugs v/hich are being imported
into the United States; or exported or offered or subject to
exports to foreign countries; or shipped or delivered for
shijffiient between states and/or territories, and/or District
of Columbia- or manufactured or sold or offered for sale in
the District of Columbia or any other territory in the U.S.V
Bills presented to the 73rd Congress and the hearings upon
those bills indicate certain v/eaknesses in the Present Food
and Drug Act, the chief criticisms being that, I) there is no
control over the advertisements of drugs not on the label or
in the package, 2) there is no regulation of mechanical dev-
ices sold for the alleviation or cure of disease, 3) there is
no control over the labeling of cosmetics, hair dyes, etc.,
and 4) the insufficiency of the word drug.
niPORTATION OF NARCOTIC DRUGS:**
Statute; " It is unlav/ful to import or bring any narcotic
drug into the United States or any territory under its control
or Jurisdiction; except that such amounts of crude opium and
coca leaves as the board finds necessary to provide for med-
icinal and legitimate uses only and for the manuf-
acture of heroin. All narcotic drugs imported under such reg-
* Taken from— Custom House Guide- 1937 ed.
** 21 U.S.C.A. ff 173
II
-x.l'J-
ulations shall be subject to the duties which are now or may
be imposed upon such drugs vj'hen imported."
EXPORTATION OF NAHCOTIC DRUGS:*
Statute ;'' (a) It shall be unlawful for any person subject
to the jurisdiction of the united States governraent to export
or cause to be exported from the United States, or from any
territory under its control or jurisdiction, or
,
any
narcotic drugs to a.nj other country. Karcotic drugs, (except
smoking opium and opium prepared for smoking, the exportation
of which is absolutely forbidden) may be exported to a country
only which has ratified and become a party to the convention
and final protocol betv/een the United States government and
other powers for the suppression of the abuses of opium and
other drugs, conn;ionly knovm as the International Opium Con-
ventiontsntvlsjKi of I9I2, and then only if (I) such a country
has instituted and maintains, in conforiiiity with that convention,
a system, v/hich the Board** deems adequate, of permits, or
licenses for the control of iriports for such narcotic drugs;
(2) the narcotic drug is consigned to an authorized permittee;
(3) there is furnished to the board proof deemed adequate by
it that the narcotic drug is to be applied exclusively to med-
icinal and legitimate uses within the country to which it is
exported, that it will not be reexported fro:;: such country aiid
that there is actual shortage for the drug
* 21 U.S.C.A. #182
**
"Board" now refers to the Commissioner of Narcotics.
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CONCLUSION:
In the light of the preceding discussion it is not difficult
to see that this industry, like many others, found its oppor-
tunity for birth through the demand of the peojle for drugs. This
naturally led to a cultivation of crude botanicals in order to
satisfy that demand, vv^hich, in turn, led to the manufacture of
these raw i.aterials. As the number of producers increased, so
did the supply of medicinals increase, leading to a different-
iation of products. tVhen the merchandise becarrie so differentiated
by manufacturers and a demand created for it, an endeavor v;as
made to hold that demand through a process of individualization
which fixed the particular brand, rather than the general ty:pe
of drug, in the mind of the purchaser.
Out of this condition rose the v/holesaler whose function was
to assemble under one roof the different branded staples for
distribution to druggists in small lots, xhe wholesaler, partly
because of his poor management and partly because of the willing-
ness of the manufacturer to grant quantity discounts, found him-
self competing with chains. The latter' s main objective was to
evade the additional cost incurred by the middleman in the dis-
tribution of drug merchandise. The success of these chains led
to a co-operative movement, the originators of v/hich had as an
objective the acquiring of quantity purchase discounts from the
manufacturer in behalf of the independent retailer . Thus v/as
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ibution.
Undoubtedly, our present marketing process is very expensive.
In the case of drugs it probably amounts to 50 per cent or
more of the price paid by the consujuer. Furthermore, the fev/
facts at hand show that there are wide variations in the expen-
ses of competing firms, particularly in the retail field. Such
data as are at hand indicate that for many retail druggists
there is a great opportunity for improvement. Valuable work
is now being done by educational institutions, manufacturers,
jobbers and by retail associations in educating the retailer
to better methods. The larger market organizations seem to be
operating more effectively, but the data for comparison are
meager. It is evident that what is needed is to continue with,
and to further develop, the work of the various agencies,
public and private, v/hich are directed toward the improvement
of the methods of retail drug merchandising.
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NOTE
:
Other inforiiiation has been gathered from the follov/ing
sources
;
Undergraduate preiiiedical class notes, 1935 and 1936.
Field trip to the United Drug Co., 1937, GR. B-9.
Field trip to E. L. Patch Co., 1937, GR. B-9.
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